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FOREWORD 
The surgical therapy of primalY and secondary hepatic neoplasms 
has changed markedly over the last 30 years, from a time when par-
tial hepatectomy was a relatively rare operation to the modem era 
when total hepatectomy and liver transplantation are being prac-
ticed in many medical centers. The members of the Starzl group, 
first in Denver and subsequently in Pittsburgh! have played a domi-
nant role in developing the surgical techniques that have made this 
possible. In this issue of Current Problems in Surgery, Drs. Iwatsuki, 
Sheahan! and Starzl describe their experience to date with almost 
500 patients whose liver tumors have been treated by aggressive he-
patectomy. Their careful review of the surgical anatomy of the liver, 
their clear, detailed descriptions of the various hepatic resections, 
and the resume of their clinical experience and excellent results 
represent an excellent overview of the field by the clinical investiga-
tors who have been primarily responsible for its establishment. 
Samuel A. Wells, Jr., M.D. 
Editor-in-Chief 
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THE CHANGING FACE OF HEPATIC 
RESECTION 
Although the first surgical removal of a portion of the human liver 
was recorded more than two centuries ago, the liver was regarded as 
a noli me tangere ("do not touch me") organ until the beginning of 
this century. This fear still exists in some degree even today. Until 10 
to 15 years ago, the operative mortality with major hepatic resec-
tions was too great to justity their use if a less dangerous, even 
though unsatisfactory, alternative was available. This is no longer a 
supportable point of view in the 1980s. Major hepatic resections can 
now be performed quite safely, and indications for the operation 
have become far less restrictive for both malignant and benign he-
patic lesions. 
Increased numbers of hepatic mass-lesions are found today by ad-
vanced imaging technology, and physicians and surgeons are asked 
frequently for their best management. Our main concerns in this 
monograph are to summarize the essential surgical anatomy of the 
liver, the basic surgical pathology, and the techniques of hepatic re-
section. We also report our experience with excisional therapy for 
benign and malignant hepatic lesions over the last 25 years. 
SURGICAL ANATOMY 
It is quite confusing when there are many different names for 
lobes and segments of the liver. For example, what is called "lobec-
tomy" in Europe is often different in meaning from the same term in 
the United States of America. "Lobectomy" in the United States is 
equivalent to "hepatectomy" in Europe while "right lobectomy" in 
Europe is called "right trisegmentectomy" 01' "extended right lobcl> 
tomy" in tIle United States, and "left lobectomy" in Europe is called 
"left lateral segmentectomy" in the United States. In Europe the liver 
is usually described as having eight segments, while it is most often 
divided into four segments in the United States. In Japan and other 
countries, European segments are called "subsegments" to avoid the 
confusion. So-called (used to be so-called! anatomical right and left 
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lobe are not "true" right and left lobes founded upon an embryologic 
or truly morphological basis. 
A large portion of the liver that lies to the right side of the falci-
form ligament was mistaken as a right lobe for a long time. However, 
in 1898, Cantlie l and, in 1927, McIndoe and Counselle~ reported 
that the division between the true right and left lobes of the liver 
was not at the falcifOilli ligament as had previously been believed, 
but rather at a line passing through the bed of the gallbladder and 
projecting posteriorly toward the vena cava (known as Cantlie's 
line). 
In the early 1950s Hjortsjo/ Elias and Petty,4 and Healey and 
Schroy5,6 demonstrated by casting studies of the liver that each true 
lobe was further divided into two segments: an anterior and a poste-
rior segment of the right lobe, and a medial and lateral segment of 
the left lobe, and that the hepatic arterial, portal venous and biliary 
duct branches conformed to the four segments (Fig 1). These obser-
vations were confirmed and extended by Couinaud7 and by Gold-
smith and Woodburne.8 Couinaud divided each of the four seg-
ments into two, resulting in a total of eight segments (subsegments) 
I 
FIG 1. 
\ 
I 
I 
I 
I, 
DrD~~-~~~ 
, \ \ 0\ ____ ~--~~stK Segment 
Right Lobe 
B 
Med, Segment Lat. Seg. 
Left Lobe 
The liver IS divided Into the right and left lobes by a sagittal plane (A). The left lobe is 
further divided into the lateral and medial segments by another sagittal plane (B). The 
right lobe is divided into the anterior and posterior segments by a coronal plane (C) . 
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FIG 2. 
Couinaud's eight hepatic segments (subsegments). The four segments shown in Figure 1 
are each further divided into two subsegments, and each segment is numbered from I to 
VIII. 
(Fig 2). The large hepatic venous branches are distributed differently 
since a number of their branches are between, rather than within, 
segments and lobes. 
For practical purposes, there are only four surgical units that lend 
themselves to controlled excision: the anterior and posterior seg-
ments of the right lobe, and the medial and lateral segments of the 
left lobe (Fig 3). Each of the eight segments proposed by Couinaud 
(see Fig 2) is not considered as a surgical unit individually because 
divisions of most of his segments are ill defined, and resections of 
most of the anterior, posterior, and medial segments alone are not 
ordinarily necessary. 
It is true, however, that the interest in subsegmental resection of 
small (less than 3 cm in diameter) hepatomas in cirrhotic liver's has 
been growing in Asia and Europe, where these small tumors are fre-
quently found in patients with cirrhosis during their regular screen-
ing with ultrasonography and serial determinations of serum tx-feto-
protein. The segments of Couinaud can be marked by injection of 
contrast media or isotope into the subsegmental branches of the 
portal vein under ultrasonographic guidance.9 - 11 The tumor-bearing 
subsegment is resected by an ultrasonic knife. Early occlusion of the 
portal venous branch is said to be important in preventing transpor-
tal dissemination of malignant cells. 
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'L Lot. Segmentectomy 
~~~ __ ~f LI ____________ ~ 
Rt. Lobectomy Left Lobectomy 
Rt. Trisegmentectomy 
Left Trisegmentectomy 
FIG 3. 
For practical purposes, there are only four surgical units (segments), and five kinds of an-
atomical resections are commonly used. 
HEPATIC ARTERY 
Most commonly, the entire arterial supply to the liver is derived 
from the celiac axis. The celiac axis divides into the common he-
patic, left gastric and splenic artery. The common hepatic artery, af-
ter giving off the gastroduodenal artery and the right gastric artery at 
the upper border of the first part of the duodenum, continues as the 
proper hepatic artery. The proper hepatic art8IY ascends within the 
hepatoduodenal ligament medial to the common bile duct and 
along the left anterior wall of the portal vein, and bifurcates into the 
right and left hepatic arteries. This bifurcation occurs at variable lev-
els between the origin of the artery and the porta hepatis (Fig 4). In 
about 4% of cases, the common hepatic artery originates from the 
superior rnesenteric artely.12,13 
The right hepatic artelY usually runs behind the common hepatic 
duct and divides into the anterior and posterior segmental branches 
either before or after entering the hepatic parenchyma with the cor-
responding segmental bile ducts. Occasionally, the right hepatic ar-
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SMA 
FIG 4. 
Schematic drawing of common variations of hepatic arterial blood supply. A artery, 
PV = portal vein, SMA = superior mesenteric artery. 
tery passes in front of the bile duct. Often, the right hepatic artery or 
the posterior segmental branch of the artery arises from the superior 
mesenteric artery and courses posteriorly and to the right of the 
portal vein in the hepatoduodenalligament (see Fig 4). 
The cystic artery usually originates from the right hepatic artery 
and runs either in front of or behind the biliary duct system. 
Frequently the cystic artery arises from the anterior branch of 
the right hepatic artery. Double cystic arteries are found occasion-
ally. 
The left hepatic artery most commonly originates from the proper 
hepatic artery and branches off into the medial and lateral segments 
at the hepatic hilum. The lateral segmental artery divides into the 
superior and inferior branches at the base of the umbilical fissure 
(fissure between the medial and lateral segments of the left lobel. 
The medial segmental artery often arises from the inferior branch of 
the lateral segmental artery, and occasionally even from the anterior 
segmental branch of the right hepatic artery. The left gastric artery 
often gives off a branch to all or part of the left liver lobe. In this vari-
ation, the artery runs in the middle of the gastrohepatic ligament to-
ward the umbilical fissure and is separate from the porta hepatis 
(Fig 5). 
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FIG 5. 
Intrahepatic distribution of the hepatic arteries and bile ducts. (1) Common hepatic artery 
(2) right hepatic artery, (3) posterior segmental artery, (4) superior posterior area artery, 
(5) inferior posterior area artery, (6) anterior segmental artery, (7) superior anterior area 
artery, (8) inferior anterior area artery, (9) left hepatic artery, (10) medial segmental artery, 
(11) superior medial area artery, (12) inferior medial area mtery, (13) lateral segmental ar-
tery, (14) superior lateral area artery, (15) inferior lateral area artery, (16) arteries to the 
caudate lobe. 
PORTAL VEIN 
The portal vein is fonned by a conlluence of the splenic vein and 
superior mesenteric vein behind the pancreas. It passes from its or-
igin behind the first pari of the duodenum and then courses toward 
the porta hepatis in the hepatoduodenal ligament, in front of the fo-
ramen of Winslow. The course of the portal vein is quite uniform, 
although rarely it may run in front of the duodenum, especially 
when there is a complex of other anomalies including gut malrota-
tion, absent retrohepatic inferior vena cava, and anomalous hepatic 
artery origin.14• 15 
In the porta hepatis, the portal vein divides into the right branch, 
which is short and wide, and the left branch, which is longer and 
narrower. The branches of the hepatic artery and the bile duct 
maintain their anterior relationship to those of the portal vein. The 
right portal vein takes a very short course before it divides into the 
anterior and the posterior segmental vein, which further divides into 
the superior and the inferior branches (Fig 6). The left portal vein 
consists of two portions: the transverse portion (pars transversus), 
which luns at the base of the medial segment (quadrate lobel; and 
the umbilical portion (pars umbilicus), which CUives forward as the 
continuation of the transverse part, lying in the umbilical fissure and 
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FIG 6. 
_~~_Coudote veins 
Post. 
segment v. 
Ant. 
segment v. 
'-..", __ "'''''-If 
Right Lobe 
Med. segment Lat. seoment 
Left Lobe 
Intrahepatic distribution of the portal vein: RPV = right portal vein, LPV = left portal vein, 
A = pars transversus, B = pars umbilicus. 
ending anteriorly in an attachment to the round ligament (liga-
mentum teres hepatisJ. The superior and inferior branches of the 
lateral segment vein arise from the left side of the umbilical portion 
of the left portal vein, and the veins to the medial segment arise from 
the right side of this same vessel. Thus, the distribution of the left 
portal vein differs from that of the left hepatic artery and the bile 
duct (see Figs 5 and 6). 
BILE DUCT 
The common bile duct runs along the right margin of the hepa-
toduodenal ligament, anterior' to the portal vein and, most often, to 
the right of the hepatic artery. The common hepatic duct which 
continues to run along the right anterolateral wall of the portal vein 
is the portion of the bile duct between the entry of the cystic duct 
and the bifurcation of the right and left bile ducts. 
The cystic duct enters the bile duct at various levels, and it often 
joins the right hepatic duct. The right hepatic arteIY passes more of-
ten behind rather than in front of the common hepatic duct (see Fig 
5). 
The common hepatic duct may bifurcate at any level in the hepa-
toduodenal ligament, but its bifurcation is usually higher than that 
of the hepatic artery and of the portal vein, and often within the sub-
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stance of the liver. The right hepatic duct is short, as is the right por-
tal vein, and branches off into the anterior and posterior segmental 
ducts, maintaining the anterior position to the corresponding portal 
branches (see Fig 5). Occasionally, there is no union of the anterior 
and posterior segmental ducts, and therefore, no true right hepatic 
duct. 
The left hepatic duct is longer than the right duct, and runs along 
the base of the medial segment into the umbilical fissure to become 
the lateral segmental duct (see Fig 5). The medial segmental duct 
most commonly enters the left hepatic duct at the right side of the 
umbilical fissure, but occasionally it drains into the inferior branch 
of the left lateral segmental duct. Nonunion of the medial and lateral 
segmental ducts is extremely rare. 
HEPATIC VEIN 
There are three major hepatic veins, which run predominantly in 
the intersegmental plane. The right hepatic vein passes between the 
anterior and posterior segments of the right lobe and drains into the 
right anterolateral ostium of the vena cava. The middle hepatic vein 
is the principal drainage for the medial segment of the left lobe, and 
its main branches are in the planes between the right and left lobes 
and between the medial and lateral segments of the left lobe. The 
terminal course of the middle hepatic vein usually is in the interseg-
mental plane between the medial and lateral segments of the left 
lobe where it may join the left hepatic vein (from the lateral seg-
ment) near the vena cava, or less commonly drain separately into 
the anterior ostium of the vena cava. The left hepatic vein drains into 
the left anterolateral ostium of the vena cava. 
Besides these three major hepatic veins, there are several short he-
patic veins draining directly from the posterior segment of the right 
lobe and from the caudate lobe into the vena cava (Fig 7) and irreg-
ularly from other parts of the posterior hepatic parenchyma. 
CAUDATE LOBE 
The medial segment of the left lobe is divided by the porta hepatis 
into the superior area (quadrate lobe) and inferior area (caudate 
lobel. The vascular and biliary branches of the caudate lobe are best 
described separately because this small area can be spared or re-
moved in the lobectomy or trisegmentectomy, depending on the lo-
cation of the hepatic lesion. 
One of the most confusing anatomical designations is the so-
called portion of the caudate lobe. The caudate lobe proper lies 
along the left side of the vena cava and extends to the fissure of the 
obliterated ductus venosus. A portion of the liver that lies in front of 
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I nferlor vena cava Caudate lobe v. 
Right hepatic v. / Middle hepatic v. 
-KKKi_~TD"D"ieKI-K:KfK:KKKt hepatic v. 
Med. Segment Lot. Segment 
Right Lobe Left Lobe 
FIG 7. 
Prevailing pattern of hepatic venous drainage. 
the vena cava is the caudate process, and the right portion of the 
caudate lobe fuses with the posterior segment of the right lobe in 
the right side of the vena cava. The branches of the portal vein to the 
caudate lobe are usually two in number, one each arising from the 
right and left portal vein branch in the porta hepatis. Thus, the cau-
date lobe is actually part of both the true right and left lobes. Ac-
cordingly, arterial and biliary duct branches, usually two or three in 
number, originate from both right and left branches. There are usu-
ally a few short hepatic venous branches draining directly into the 
anterior and left walls of the vena cava. 
LOBAR AND SEGMENTAL HEPATIC RESECTION 
Five lobar andlor segmental anatomical resections of the liver can 
be applied safely to various locations of hepatic lesions. They are 
right and left trisegmentectomy, right and left lobectomy, and left 
lateral segmentectomy (Fig 8). In Europe, the term "right hepatec-
tomy" or "left hepatectomy" is used for the right lobectomy or left 
lobectomy of the liver. It is incorrect to call the right trisegmentec-
tomy a right lobectomy, or to call a left lateral segmentectomy a left 
lobectomy. 
With right trisegmentectomy, the right lobe of the liver and the 
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RT. TRISEGMENTECTOMY LT. TRISEGMENTECTOMY 
RIGHT LOBECTOMY LEFT LOBECTOMY 
NON·ANATOMICAL RESECTION LT. LATERAL SEGMENTECTOMY 
FIG 8. 
Schematic drawings of five truly anatomical resections and a nonanatomical resection. 
medial segment of the left lobe are removed, except that the left pos-
terior portion of the caudate lobe (caudate lohe proper) may be re-
moved or retained depending upon the location of the tumor. With 
left trisegmentectomy, the left lobe of the liver and the anterior seg-
ment of the right lobe are removed, but the caudate lobe proper may 
be resected or retained, as with right trisegmentectomy, depending 
upon the location of the tumor. 
The term "extended right lobectomy" usually refers to a right tri-
segmentectomy. However, it may also refer to a slight modification of 
right lobectomy in which the hepatic parenchyma is transected well 
to the right of the falciform ligament rather than at this ligament, 
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thus sparing most of the medial segment. Extended right lobectomy 
with the latter meaning is a nonanatomical resection, which does 
not differ from the right lobectomy in preparation for actual hepatic 
parenchymal transection, as is described in a later section. The 
same is true for the so-called extended left lobectomy, which should 
not be confused with the left trisegmentectomy since it does not re-
sult in removal of the full anterior segment of the right lobe. There-
fore, extended right and left lobectomy are classified as right and left 
lobectomy in the analysis for this text of our cases. The categories of 
hepatic resections in this text are shown in Figure 8 and consist of 
the five formal resections just delineated plus "nonanatomical" or lo-
cal excisions. 
SUBSEGMENTAL AND LOCAL EXCISIONAL RESECTIONS 
In Japan, Italy, and France, there has been a wave of enthusiasm 
for smaller resections in patients whose livers are cirrhotic.9 - 11 , 16-20 
Any of the four principal segments can be removed, and for that 
matter so can the subsegments (the segments of Couinaudl. Accu-
rate delineation of the region to be excised has been facilitated by 
intraoperative ultrasonography,9-11 and by the injection of dyes into 
the portal or arterial blood supply. Many of the excisions classified 
by us as "local" were resections of this kind. However, we have not 
used these resections in cirrhotic patients sufficiently to warrant 
personal opinions about their value. The reader is referred to more 
authoritative sources.9- 11 , 16-20 
The term "local" can be misleading. Some of the largest masses re-
moved by us were either along nonanatomicallines, or could be re-
moved with segments or subsegments only. 
MILESTONES OF HEPATIC RESECTION 
Although many hepatic resections had been carried out success-
fully before the turn of this century, these should rather be consid-
ered as uncontrolled amputations of hepatic lesions21,22 inasmuch 
as the precise anatomy of the liver was not well known until the 
middle of the 20th century. Wendef3 has been credited with the 
first successful right lobectomy in 1911. He was convinced that his 
success was due to early ligation of the right hepatic artery and the 
biliary duct and covering of the cut hepatic surface with the gall-
bladder. He preserved the cystic artery and duct. Although Keen22 or 
Abel24 had been said to be the first surgeons to carry out left lobec-
tomy, their operations were not true left lobectomies, but rather left 
lateral segmentectomies (removal of the liver left of the falciform lig-
ament). We are not certain who performed the first true left lobec-
tomy. 
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On the other hand, the record is clear that Lortat-Jacob and Rob-
ert first described right trisegmentectomy (removal of the liver to the 
right of the falciform ligament) in any detail.25 \Vangensteen2(; may 
have actually done this operation earlier, and Quattlebaum27 was 
the first to describe the operation in the English literature. The op-
eration became known as extended right lobectomy, and included 
partial removal of the quadrate and caudate lobes. Enthusiasm for 
this operation apparently was dampened by a high mortality re-
ported by Bruhschwig2/\ and others.2g The procedure was virtually 
abandoned until subsequent refinements of the operative tech-
niques and documentation of the safety of the operation.30• :11 
The most recently described anatomic hepatic resection is left tri-
segmentectomy or a complete removal of the anterior segment of 
the right lobe along with the true left lobe. This operation was per-
formed for the first time in 1980 and reported with three additional 
cases in 1982.:12 
At least two other great milestones of hepatic resection cannot be 
neglected. One is that of Raven,33 and another is that of Pringle.34 Al-
though Wendel23 had recommended the early ligation of the right 
hepatic artery and bile duct in U111, Raven33 was the first to describe 
the systematic ligation of the hepatic hilar structures in his 1949 re-
port. 
The Pringle maneuver for controlling hemorrhage from the liver 
during surgery is well known and widely practiced. Huguet and as-
sociates35 documented that the human liver can tolerate total occlu-
sion of hepatic blood inflow for over an hour. Todo and associates36 
showed with an ingenious experimental model that dogs can toler-
ate total warm ischemia of the liver for up to 3 hours. 
Recent advances in medicine such as the development of modern 
anesthesia, safe blood transfusion, countless effective antibiotics, 
and sophisticated technology in diagnosis and monitoring have con-
tributed to the rapid progress in hepatic surgery of today. 
Finally, total hepatectomy with replacement (orthotopic liver 
transplantation) has evolved from experimental to practical therapy 
in recent years.37- 39 
OUR TECHNIQUES OF HEPATIC RESECTION 
INCISION AND EXPOSURE 
All-purpose incisions for hepatic surgery are shown in Figure 9. 
The basic incision is a bilateral subcostal incision to which an upper 
midline extension usually is added (see Fig 9). The right side of the 
subcostal incision (points A-B) usually is longer than the left side 
(points A-D). If the upper midline extension (A-C) includes com-
plete removal of the xiphoid process, exposure of the suprahepatic 
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FIG 9. 
Commonly used incisions for hepatic resection. 
abdominal vena cava and the main hepatic veins is improved. A tho-
racic extension (E-F) into the eighth intercostal space is rarely nec-
essary even for very large tumors. In many cases a right subcostal 
incision with an upper midline extension (A-B plus A-C) gives ad-
equate exposure. 
When the costal angle is narrow, a J-shaped incision as shown in 
Figure 9, B can be used. In children a rather flat bilateral subcostal 
incision as shown in Figure 9, C can be used, without the midline 
extension. We apply self-holding retractors (Rochard retractor) to the 
right and left costal margins in order to obtain steady satisfactory ex-
posure. 
RIGHT-SIDED HEPATIC RESECTIONS 
The procedures of right trisegmentectomy and right lobectomy 
are described together in this section. 
Exploration and Early Mobilization of the Right Lobe 
After having obtained a satisfactory exposure and ruling out the 
possibility of extrahepatic metastases, a decision is made about the 
extent of hepatic resection, and a plan is developed for the steps of 
dissection. The sequence of the operation may vary from case to 
case depending upon the location and size of the lesions. Usually 
the attachment of the right colon (hepatocolic ligament) and the 
prerenal peritoneum (renohepatic ligament) are separated from the 
inferior surface of the liver. The right triangular and coronary liga-
ments may be incised at this time. If this is done, the right bare area 
can be broadly entered (Fig 101. By so doing, it become::; possible to 
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Preliminary mobilization of the right hepatic lobe. (From Starzl TE: Experience in Hepatic 
Transplantation. Philadelphia, WB Saunders Co, 1969, p 51. Used by permission.) 
elevate the right lobe into the wound and to retract it toward the left 
freely when this maneuver becomes necessary later (Fig 11). 
Early mobilization of the right lobe is an optional luxury, the fea-
sibility of which depends on the location of the lesion. If mobiliza-
tion is difficult, or if the right hepatic vein cannot be seen or encir-
cled easily, it can be approached from within the liver during the pa-
renchymal transection (see later). The intraparenchymal approach 
to the right hepatic vein is especially useful when the tumor is fixed 
to the diaphragm or to the adrenal gland or right kidney.31 In such 
cases, the diaphragm, adrenal gland, or kidney can be included with 
the liver specimen as the last step in the extirpation. Having settled 
on the final incision and having decided for or against preliminary 
right lobar mobilization, attention is then turned to the hepatic 
hilus. 
Hilar Dissection 
There are numerous variations of hepatic hilar structures, particu-
larly of the hepatic artery as described in the previous section. In the 
past we thought that the dissection of the hilar structures would be 
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Several small short hepatic veins are ligated and divided as they enter the vena cava. The 
right hepatic vein is divided between vascular clamps and oversewn with vascular su-
tures. I. v.c. = inferior vena cava. (From Starzl TE et al: Surg Gynecol Obstet 1975; 
141 :435. Used by permission.) 
so greatly facilitated by prior knowledge of the arterial blood supply 
of the liver that elective hepatic resection should never be perfOImed 
without preoperative angiography.30 
For the last 10 years, however, we have not used preoperative an-
giography for this purpose because the intraoperative examination 
of the hilar structures by inspection and palpation is quite sufficient 
to determine all variants of the hepatic arterial blood supply. The 
first step is to look for an artery in the gastrohepatic ligament to the 
left of the portal triad. A vessel here is usually a left segmental Of' lo-
bar branch and when present it usually comes from the left gastric 
artery. The branch enters the liver at the base of the umbilical fissure 
(between the medial and lateral segment) (see Fig 4). Then, a left in-
dex finger is inserted into the foramen of Winslow and pulses are 
palpated (Fig 12). If a pulse is found to the left of the common duct 
anterior to the portal vein, it is almost certainly from the celiac axis 
(Fig 13). A pulse posterior to the portal vein is a sure sign of an artery 
that has originated from the superior mesenteric artery. This anom-
alous vessel usually supplies part or all of the right lobe of the liver, 
but it also may supply part of the left lobe as well or even the entire 
liver. 
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FIG 12. 
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Intraoperative examination of hepatic arterial blood supply. (From Starzl TE: Experience in 
Hepatic Transplantation. Philadelphia, WB Saunders Co, 1969, p 52. Used by permission.) 
The first step in dissecting the hilum is to free, ligate and divide 
the cystic duct and artery (see Fig 13). The cystic artery usually 
arises from the right hepatic artery. By dividing the cystic artmy and 
duct, the bifurcation and especially the right branches of the hilar 
structures can now be identified more easily and safely. The right 
hepatic artery is sacrificed first (see Fig 13). The hepatic arterial vari-
ations are so numerous that the ligation should never be perfonned 
without preliminary test occlusion and without being sure that dur-
ing this test occlusion there are arterial pulsations going to the frag-
ment to be retained whether this be the full left lobe or the left lat-
eral segment. 
After dividing the right hepatic artery and clearing the perito-
neum, lymphatics, and nerve tissue, the right branch of the portal 
vein is encircled, ligated, and divided if it is long enough. If it is 
short, it is divided between vascular clamps, and the proximal ends 
closed vvith continuous 6-0 proline suture (see Fig 13). If any diffi-
culty with exposure is encountered because of overhanging tumor, 
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Devascularization of the right lobe is completed. The bifurcation of the bile duct is almost 
always the most superior structure and is often inside the liver. I.v.c. = inferior vena cava; 
G.b. = gallbladder. (From Starzl TE et al: Surg Gynecol Obstet 1975; 141:431. Used by 
permission.) 
the portal vein can be easily approached laterally or posteriorly, 
when the liver is retracted anteriorly to the right (Fig 141. This poste-
rior approach is especially helpful if vein branches emanate from the 
back of the portal bifurcation, as is often seen. 
After dividing the right hepatic artery and the right branch of the 
portal vein, a line of demarcation becomes evident between the true 
right and left lobe through the bed of the gallbladder and directed 
toward the vena cava. If the line of demarcation is not evident or is 
far to the right of the expected line, further search for missed he-
patic arterial or portal branches is necessary. 
Of the three triad structures, the common hepatic duct almost al-
ways has the most superior bifurcation, so high in fact that the divi-
sion may be within the substance of the liver (see Fig 13). The right 
branch of the duct is near the base of the gallbladder bed, where it 
can come off like a crossbar from a T. In anomalous cases, the cystic 
duct can join the right hepatic duct, but this will have been discov-
ered usually with the cystic duct dissection and ligation. The right 
duct is ligated and divided, but only after a definite duct has been 
demonstrated to pass to the retained left fragment of liver. (Injury to 
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FIG 14. 
Posterior approach in dissecting the bifurcation of the portal vein. I. V.C. = inferior vena 
cava. (From Starzl TE et al: Surg Gynecol Obstet 1975; 141 :432. Used by permission.) 
the duct system is probably the most common technical error com-
mitted today in performing hepatectomies.) At this point the hilar 
dissection of the right hepatic lobectomy has been completed. When 
it has been possible to divide the right hepatic vein, the stage is set 
for removal of the specimen. Additional dissection of the left 
branches are necessary if right hepatic trisegmentectomy is to be 
performed. 
Additional Hilar Dissection for Right Trisegmentectomy 
Before proceeding further, the exact location of the umbilical fis-
sure (left lateral segmental fissure) must be determined. In many hu-
man livers, the umbilical fissure is concealed by a fusion of the lips 
of the medial and lateral segments of the left lobe (Fig 15). Even if the 
fusion is complete and involves a large surface, no large structures 
pass through it and it can be readily opened with finger fracture (see 
Fig 15). In the base of the opened field lies the true umbilical fissure. 
The groove running from the bifurcation of the portal stIuctures to 
the left contains the left lobar branches. It is called pars transversus 
(transverse portion) and is several centimeters in length. It runs 
along the base of the quadrate lobe, dividing the medial segment of 
the liver into the quadrate and caudate components. As the left triad 
structures are mobilized from the transverse groove, the first 
branches pass posteriorly to the left portion of the caudate lobe. If a 
decision is made to sacrifice these branches (see Fig 15), the caudate 
lobe will be devitalized, and, ideally, it should be removed entirely 
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FIG 15. 
Nearly completed division of fine branches from the transverse part of portal triad struc-
tures. The branches to the caudate lobe should be preserved unless all of the caudate 
lobe is to be removed. The tissue bridge is being broken down to permit access to the 
umbilical fissure. (From Starzl TE et al: Surg Gynecol Obstet 1975; 141 :433. Used by per-
mission.) 
from the wall of the inferior vena cava and from its junction with the 
lateral segment. If these posterior branches can be retained, the in-
trinsic risk of right trisegmentectomy is undoubtedly reduced by 
preserving a larger hepatic fragment. However, total extirpation of 
the caudate lobe is unavoidable if a good margin is to be obtained. 
Except for early branches to the caudate lobe, usually there are 
few, and sometimes no, branches from the triad structures in the 
course of the pars transversus. However, these must be looked for, 
meticulously dissected, and doubly ligated and divided (see Fig 15). 
If there is a variant artery arising from the left gastric artery or from 
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the celiac axis (see Fig 4) to the entire left lobe or to the left lateral 
segment, it almost always enters the base of the umbilical fissure 
considerably to the left of the field of dissection of the pars transver-
sus. This anomaly, if recognized early, is a technical advantage since 
its presence virtually eliminates the danger of dearterializing the re-
maining left lateral segment during dissection in the transverse 
groove. The dissection of the pars transversus from right to left is 
stopped short of the umbilical fissure (see Fig 15) if the structures 
become buried in the hepatic parenchyma, which frequently is the 
case. 
In some patients, the further division of the triad structures into 
medial and lateral segmental branches can be seen easily. If this nat-
ural advantage is present, cautious dissection, ligation, and division 
of those branches feeding back to the medial segment can be done 
now, working from the base of the umbilical fissure anteriorly. Any 
difficulty in dissection or ambiguity about what is being freed must 
prompt immediate discontinuance of such efforts, which could lead 
to damage of the structures going to the lateral segment. The safest 
technique will be to deal with the "feedback" structures to the me-
dial segment at the time of parenchymal transsection. 
The Hepatic Veins 
If the right hepatic vein has not been dealt with at an earlier time, 
it is approached by cautious dissection as the right lobe is retracted, 
and it is encircled. This can be dangerous because the right hepatic 
vein is short outside the liver and a tear during its dissection may 
create a large defect at its junction with the suprahepatic inferior 
vena cava that can be difficult to control or repair. The encircled 
right hepatic vein is doubly clamped with angled pediatric vascular 
clamps, and divided and sewn shut on both sides with continuous 
vascular sutu/'eS (see Fig 11). 
The right hepatic vein and a somewhat smaller posterior hepatic 
vein which is one of the most inferior veins are sacrificed with either 
right lobectomy or right trisehwentectomy. Judgment must be exer-
cised about the intervening hepatic veins, the more conservative ap-
proach in sparing vessels being with the true right lobectomy. With 
either lobectomy or trisegmentectomy, the entire length of the retro-
hepatic vena cava is exposed by careful sharp dissection (Fig 16). 
The right adrenal gland is pushed back into the retroperitoneum 
and the adrenal vein should not be injured. The smaller hepatic 
veins which seem to enter from the specimen being developed into 
the anterior surface of the retrohepatic vena cava are doubly ligated 
and divided. 
When right trisegmentectomy is performed, all of the caudate lobe 
may be removed or its left portion may be spared by leaving intact 
the first branches of the left triad structures (see earlier). If the deci-
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After preliminary mobilization the right lobe is gently retracted anteriorly and to the left. The 
entire length of the retrohepatic vena cava is exposed by careful dissection. I. V.C. = infe-
rior vena cava; R.H. V. = right hepatic vein. (From Starzl TE: Experience in Hepatic Trans-
plantation. Philadelphia, WB Saunders Co, 1969, p 116. Used by permission.) 
sion is for comfJlete caudate removal, four to eight small hepatic 
veins from this piece of liver are ligated and divided on the anterior 
left wall of the vena cava. With this radical step, the left hepatic vein 
is the sole source of venous drainage of the lateral segment. 
The Parenchymal Transections With Right Lobectomy and Right 
Trisegmen tecto my 
Right Lobectomy.- The devascularized right lobe can be seen by 
the color demarcation in the anteroposterior plane that runs from 
the gallbladder bed toward the inferior vena cava. The cyanotic liver 
includes the right portion of the caudate lobe. The transection is in 
this plane, beginning from the edge of the liver with a combination 
of ligatures, clamps, knife handles, or fingers according to the sur-
geon's preference. As the transection moves toward the inferior vena 
cava, the fusions of the left part of the caudate lobe with the right 
caudate portion and with the posterior segment of the right lobe are 
opened up on the anterior aspect of the vena cava. 
Development of the interlobar plane is made easier if an interlobar 
vein can be located as a "pathfinder." Such a vein, is usually a main 
branch of the middle hepatic vein, and normally branches of the 
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vein are the only big structures that cross the interlobar fissure. In 
unusual cases, triad structures originating from the left branches 
may cross the fissure to supply a portion of the right lobe, but these 
structures are automatically encountered and ligated as the plane is 
developed. 
Right Trisegmentectomy.- The additional steps preparatory to 
right trisegmentectomy have already been mentioned. However, the 
crucial distinction between right trisegmentectomy and right lobec-
tomy is the identification and ligation during trisegmentectomy of 
the complex of arterial, portal, and ductal structures that originate 
in the umbilical fissure and feedback from the main left trunks to 
the medial segment of the left lobe. These have been called "feed-
back structures," and ordinarily they are buried in the hepatic pa-
renchyma. Only after the occlusion of the feedback vessels does the 
medial segment become cyanotic. Although the feedback structures 
originate in the umbilical fissure, they are not dissected there unless 
FIG 17. 
lure :J 
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'eft lobe 
Structures feeding back from the umbilical fissure to the medial segment of the left lobs. 
A, these structures are found in the liver substance just to the right of the falciform liga-
ment and umbilical fissure. Note that hepatic tissue bridge has been broken down. B, the 
three segments of the specimen are now devascularized. (From Starzl TE. et al: Surg Gy-
neco/ Obstet 1975; 141434. Used by permission) 
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they can be clearly seen. Instead, the feedback structures usually are 
approached within the substance of the liver, just to the right of the 
falciform and round ligaments. The parenchyma of the liver can be 
crushed down to them, either with clamps and ligature or with fin-
gers (Fig 17). 
With all three segments devascularized, the liver is transected 
from below toward the diaphragmatic surface at the exact line of 
color demarcation (see Fig 17) in the same way as with lobectomy, 
fingers using intersegmental veins for guidance. These veins are kept 
intact with the lateral segment when possible. The transection of the 
liver is facilitated by pushing down the right side of the liver with 
the left hand of the operator to open the cleavage plane. The middle 
hepatic vein which drains the medial segment is ligated near the di-
aphragm. It either enters separately into the inferior vena cava or, 
more commonly, it joins the left hepatic vein to form a short com-
mon trunk (Fig 18). 
Injury or stricture of the left hepatic vein must be prevented by 
cautious identification of the middle and the left hepatic vein. A 
stricture of the left hepatic vein will lead to acute Budd-Chiari syn-
drome and uncontrollable hemorrhage from the cut surface of the 
liver. If the lateral segment is left with its normal drainage, the frag-
struClures 
~ .. 
FIG 18. 
Nearly completed liver transection for right trisegmentectomy along exact line of color de-
marcation. The last major structure to be encountered is the middle hepatic vein. Injury to 
the left hepatic vein must be avoided. /.v.c. = inferior vena cava, C.d. = common bile 
duct, H.a. = hepatic artery, P.V. = portal vein. (From Starzl TE et al: Surg Gynecol Obstet 
1975: 141 :436. Used by permission.) 
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ment can accommodate the portal venous flow immediately without 
any portal hypertension.3D 31 
Division of the right hepatic vein from within the liver and the use 
of this technique to help remove adjacent diaphragm or organs were 
mentioned earlier (Fig 19). 
LEFT-SIDED HEPATIC RESECTION 
The operative procedures of left lateral segmentectomy) true left 
lobectomy and left trisegmentectomy are described together. 
E((pioration and Mobilization of the Left Lobe 
As with the right-sided resections, the initial step of left-sided he-
patic resection is the identification of the hepatic arterial supply. 
The left hepatic artery originate~ either from the common hepatic 
artery or the left gastric artery. If there is an anomolous artery of left 
gastric origin it may supply the whole left lobe or only the lateral 
segment (see Fig 4). 
If a left lobectomy or left trisegmentectomy is planned, or usually 
even for left lateral segmentectomy mobilization is begun by division 
Lorqe tumor 
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Control of right hepatic vein from within the liver nearly at the end of liver transection. 
I.v.c. = inferior vena cava. (From Starzl TE et al: Surg Gynecol Obstet 1980; 150:2. Repro-
duced with permission.) 
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of the round ligament (ligamentum teres hepatis) and incision of the 
falciform ligament toward the suprahepatic part of the inferior vena 
cava. The left lobe can be lifted anteriorly and retracted to the right 
after division of the left triangular ligament and incision of the left 
coronary ligament. The small left bare area is developed so that the 
suprahepatic vena cava is exposed and the entrance of the left 
phrenic vein into the left hepatic vein is visualized. 
Hilar Dissection 
With the mobilized left lobe retracted into the wound! the princi-
pal left lobar branches of the portal triad can be approached safely 
from their posterolateral aspect (Fig 20). With this maneuver! the 
posteriorly located left portal vein is turned so as to become the 
most exposed of the triad structures. The left portal vein is dis-
sected, encircled, and divided first. The hepatic artery and then the 
left branch of the duct are ligated and divided (see Fig 20). The exact 
location of the ligations determines whether the caudate process is 
to be removed since the first branches of the left triad structures go 
posteriorly to the left portion of the caudate lobe. If the caudate pro-
FIG 20. 
Exposure of the left hilar structures is accomplished by retracting the lateral segment of 
the left lobe anteriorly and to the right. If the left portion of the caudate lobe is removed, it 
must be dissected from the vena cava, and a few small hepatic veins must be ligated, 
(From Starzl TE et al: Surg Gyneco/ Obstet 1982; 155:4. Used by permission.) 
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cess is to be retained the ligatures must be beyond these branches. 
For the left lateral segmentectomy, dissection is more distal, 
within and to the left of the umbilical tissue. Ligatures are placed far 
enough distally to preseIve the feedback vessels. 
When these steps are completed, the devascularized portion of 
the liver becomes cyanotic. When the main left triad structures are 
ligated, the color demarcation is in the middle of the gallbladder bed 
(Fig 21). If true left lobectomy is planned, the gallbladder is removed 
to allow accurate development of the lobar plane. 
Hepatic Vein 
The left hepatic vein is shorter than the right one, whether it emp-
ties separately into the suprahepatic vena cava or into the middle 
hepatic vein to form a common trunk. In performing lateral segmen-
tectomy, the hepatic vein usually should be dealt with towards the 
end of the liver transection since it is too dangerous to attempt to 
encircle it. However, with full lobectomy or left trisegmentectomy, 
the exposure is more complete, and it is often possible to dissect 
free, clamp, and close with suture the left and middle veins, or a 
common trunk when this is present. If the caudate process is to be 
removed, several branches entering the left or anterior wall of the 
retrohepatic vena cava must be dissected, doubly ligated, or sutured 
and divided. 
FIG 21. 
Completion of the left hilar dissections and divisions. The caudate lobe is spared. Note the 
color demarcation and the posterior inciSion along the obliterated ductus venosus. (From 
Starzl TE et al: Surg Gynecol Obstet 1982; 155:4. Used by permission.) 
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The Parenchymal Transections 
Lateral Segmentectomy.- The transection line is along the left 
side of the falciform ligament anteriorly and along the fissure of 
obliterated ductus venosus (fissure between the caudate process 
and the lateral segment) posteriorly. The feedback vessels to the me-
dial segment of the left lobe must be preserved, as well as the he-
patic duct. Near the end of liver transection the left hepatic vein and 
often the middle hepatic vein are encountered. The middle hepatic 
vein must not be harmed. The left hepatic vein is skeletonized as the 
last connection to the specimen, clamped, and sutured with a con-
tinuous vascular technique. 
Left Lobectomy.- The color demarcation runs from the gallblad-
der bed toward the inferior vena cava, ending at the fissure of oblit-
erated ductus venosus posteriorly if the caudate lobe proper is to be 
spared (see Fig 21). If the caudate lobe proper is removed, the ante-
rior wall of the retrohepatic vena cava is completely exposed (see Fig 
20). The cleavage plane can be developed from the hilum from the 
ligament of the obliterated ductus venosus, or by a retrograde tech-
nique from above downward. The left and middle hepatic veins Of' 
the common trunk can be skeletonized and sewed shut near the 
end of the transection, as described under lateral segmentectomy if 
this was not feasible earlier. 
Left Trisegmentectomy.-As with left lobectomy, the liver transec-
tion can start posteriorly along the fissure of the obliterated ductus 
venous or behind the left portion of the caudate lobe just in front of 
the vena cava (see Figs 20 and 21). With this approach, the left and 
middle hepatic veins already should have been crossclamped and 
sutured. The left side of the liver is then lifted anteriorly and re-
tracted to the right. An intersegmental plane must be found between 
the anterior and posterior segments of the right lobe, both of which 
still have an intact blood supply (Fig 22). It is wise to clamp the por-
tal triad structures at the hilus temporarily (Pringle maneuver) dur-
ing this part of the operation. The Pringle maneuver not only re-
duces the blood loss but also facilitates the identification of arterial, 
portal venous, and biliary branches which are to be preserved. 
The cleavage plane usually is begun at the diaphragm, keeping an-
terior to the right hepatic vein (see Fig 22). A resistance-free plane is 
sought with the dissection finger (see Fig 22), and all strands en-
countered are clamped or ligated. Downward traction is continued, 
and inferiorly the dissecting finger should emerge near the base of, 
and at right angles to, the gallbladder bed (Fig 23). Near the porta 
hepatis, still inside the substance of the liver, anterior branches of 
the right triad structures are encountered and individually ligated. 
In some livers there is a natural transverse groove near the base of 
the gallbladder that delineates the plane between the anterior and 
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FIG 22. 
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Superior to Inferior scalping of the anterior segment of the right lobe. Note that the dissect-
ing finger is kept anterior to the right hepatic vein, the left and middle hepatic veins having 
been ligated or sutured. (From Starzl TE et al: Surg Gynecol Obstet 1982; 155:5. Used by 
permission.) 
posterior segment at the hilus, and which allows the anterior seg-
mental branches to be dissected, ligated, and divided in a conven-
tional way. Under these circumstances, the transection for the left 
trisegmentectomy can be conducted from the hilum toward the di-
aphragm. Test clamping of the anterior branches marks the anterior 
segment by cyanotic discoloration. When the transection is begun 
from the hilus to the diaphragm, the specimen is lifted forward and 
retracted upward, while protecting the vital posterior structures 
from injUiy. Anterior branches are expeditiously and cautiously li-
gated and divided (Fig 24). 
BEFORE CLOSURE 
Complete hemostasis is the key in preventing postoperative mor-
tality and morbidity after any resection. If the correct plane has been 
developed, the cut surface of the liver is pink and well vascularized. 
Since residual bleeders are not covered by devitalized tissue, they 
can be easily identified and suture ligated. The cut surface of the 
liver after left lateral segmentectomy or after right trisegmentectomy 
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FIG 23. 
Further development of plane between the anterior and posterior segment of the right lobe 
of the liver. (From Starzl TE et al: Surg Gynecol Obstet 1982; 155:5. Used by permission.) 
FIG 24. 
Alternative approach with which the anterior segment is scalped from the hilus of the liver 
to the diaphragm. (From Starzl TE et al: Surg Gynecol Obstet 1982; 155:6. Used by per-
mission.) 
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is small, and it is remarkably dry, when the appropriate cleavage 
plane is followed. On the other hand, the cut surface of the liver af-
ter left trisegmentectomy is broad and presents an unfamiliar sight 
for most surgeons (Fig 25). However, even with this operation, pre-
cise visualization of the residual bleeding points is possible after dis-
continuance of the Pringle maneuver. No effort is made to cover the 
cut sllIface with living tissue or prosthetic materials. Large suture 
ligatures to close the cut sllIface are avoided because they may ob-
struct the remaining major anatomic structures. 
With left trisegmenLectomy, the extent to which the remain-
ing ducts are exposed is so much greater than with other kinds 
of anatomic resections that the risks of bile fistula and duct injury 
or positional distortion are increased. Attention is paid to meticu-
lous closure with fine sutures of minute bile leaks from the exposed 
ducts. Even if the residual posterior duct is not distorted, kinked, 
or injured it is advisable to sLent the duct and to drain it with a 
T-tube. An intraoperative cholangiogram should be obtained. This 
precautionary step not only confirms the integrity of the duct sys-
tem, but also identifies sites of biliary leakage. The small leak-
ing points are easily identified and closed with fine suture while a 
small amount of saline or diluted methylene blue is injected into the 
duct. 
FIG 25. 
Operative field after completion of left trisegmentectomy. (From Starzl TE et al: Surg Gyne-
col Obstet 1982; 155:6. Used by permission.) 
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The same precaution of cholangiography is worthwhile for other 
kinds of resections although we usually do not use T -tube biliary 
drainage except for left trisegmentectomy. One or two Jackson-Pratt 
closed suction catheters are placed near the cut surface in the sub-
phrenic space before closure. 
SURGICAL PATHOLOGY 
DIAGNOSTIC CONSIDERATIONS 
Hepatic tumors from the point of view of hepatic resection may be 
grouped into five categories: 
1. Benign lesions with expectancy of cure. 
2. Metastatic lesions limited to an anatomical region of the liver 
that permits their resection with expectation of increased lon-
gevity. 
3. Primary malignant tumors limited to anatomical regions of the 
liver that permit their resection with expectation of cure or 
increased longevity. 
4. Primary malignant tumors and rare benign lesions occurring 
diffusely throughout the liver treated by total hepatectomy 
with liver or organ cluster transplantation. 
5. Unresectable tumors. 
This discussion will focus largely on lesions in categories 1, 2, and 
3, with occasional reference to those in the other two categories. 
NEEDLE BIOPSY AND FINE NEEDLE ASPIRATION BIOPSY 
It is critical, especially with needle biopsy and fine needle aspi-
rate, to be certain that tissue has been obtained from the lesion 
,¥ithin the liver. Furthermore, we do not believe that most discrete 
lesions should require preoperative needle biopsies when they are 
to be removed surgically. 
Needle biopsy and fine needle aspiration provide diagnostic infor-
mation in approximately 40% to 75% of cases when performed in a 
"blind" fashion. When more extensive disease is present there is a 
greater yield.40 • 41 If biopsies guided by computed tomography leT) 
and ultrasonography are used the diagnostic yield approaches 
95% 42-44 Despite the advantages of entering surgery with an estab-
lished diagnosis, we usually do not perform these procedures as 
part of our workup. They have a small but significant complication 
rate. When an operation is planned in any case, we do not believe 
that the risk is justifiable. 
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FROZEN SECTION DIAGNOSIS 
Reciprocally, the pathologist who is fully informed about the le-
sion has the optimal opportunity to establish the most accurate di-
agnosis. The pathologist should ideally attend the operating room 
and personally visualize the gross location and extent of the tumor. 
Establishing the true nature of most hepatic tumors is not too diffi-
cult, but there are certain situations where it may be impossible to 
establish with certainty, on the basis of frozen section, the precise 
tumor type or whether it is benign or malignant. 
The determination as to whether a lesion is a hepatic adenoma or 
a well-differentiated hepatocellular carcinoma may not be feasible 
on frozen section and, on occasion, may best be deferred. This does 
not significantly alter the surgical approach to the resectable lesion 
or the patient's immediate postoperative management. Similarly, the 
.true characterization of the neuroendocrine nature of the lesion 
may have to await immunohistological or electron microscopic con-
fiImation. Histologic subtleties, including a suggestion of nuclear 
palisading 01' a more uniform cell population, may serve to alert the 
pathologist initially to the possible neuroendocrine origin of the tu-
mor. 
Angiography, ultrasonography, CT, and radionuclide scanning do 
not always provide a clear diagnostic picture, and the pathologist 
should be aware of such facts in correlating data from these studies 
with the morphological appearances. 
In unselected series of liver tumors metastatic carcinoma is the 
most common neoplasm. However, in series of patients undergoing 
hepatic resection for hepatic malignancy, such as the one that is the 
basis of this report, primary tumors are as frequent as metastatic tu-
mors. Also in our series of patients there was an equal incidence of 
primary and metastatic sarcomatous lesions of the liver. 
Only 50')0" of angiosarcomas of the liver al'e correctly diagnosed 
preoperatively,45 and their differential diagnosis includes leukemic 
infiltrates involving the sinusoids, other sarcomata and, on occasion, 
poorly differentiated primary or metastatic spindle cell carcinoma in 
the liver. The ditferentiation of cholangiocarcinoma from metastatic 
adenocarcinoma may be impossible in specific instances and in oth-
ers is resolved only following lengthy histologic and histochemical 
evaluation. 
BENIGN LESIONS 
Hemangioma 
This is the most common of all hepatic tumors 46, 47 It occurs at all 
ages, with roughly equal sex distribution. The tumor is usually soli-
tary but multiple lesions do occur. They frequently extend to the 
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FIG 26. 
Giant cavernous hemangioma. 
liver capsular surface, are red-blue-purple and usua]]y well circum-
scribed . The lesion in vivo is compressible and will reexpand to its 
fonner size when the compressive force is removed. Cut surface of 
the tumor shows a spongelike or honeycombed appearance from 
which blood is freely expressible . Varying degrees of scar tissue re-
sultant from organization of thrombosed and infarcted areas may 
provide a finn white appearance to focal areas of the tumor (Fig 26). 
Histologically a typical cavernous hemangioma is composed of 
anastomosing vascular channels of varying caliber lined by flattened 
endothelial cells with hyalinized and focally calcified fibrous stroma. 
Occasional phleboliths occur. 
Infantile Hemangioendothelioma 
This is the mos t common vascular tumor in children 48 It is fre-
quently multiple and may be assoc iated with similar lesions in other 
organs. Patients with these lesions may have an abdominal mass, 
high output cardiac failure, or jaundice. Grossly the liver contains 
multiple circumscribed masses measuring up to 3 em in diameter, 
with gray-white borders and dark blue centers . Capsular rupture 
may occur. Microscopically this lesion shows two histologiC pat-
terns :l~ The most common (ty pe Il shows vascular channels of V31y -
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ing size lined by plump endothelial cells showing rare mitoses. 
These lesions may be associated infrequently with the subsequent 
occurrence of angiosarcoma. In comparison, the other type (type III 
is a more densely cellular lesion and shows a greater degree of pleo-
morphism. This variant may show areas of cavernous hemangioma, 
areas similar to type I lesion or areas of angiosarcoma as indicated 
by regions of intravascular endothelial proliferations, infarction and 
hemorrhage. 
These observations make it difficult to predict the biological be-
havior of this tumor variant from its histologic appearance.49 There 
is a similar lack of uniformity in its ultrastructural appearance which 
presumably reflects its multiple histologic patterns. 
Liver Cell Adenoma 
This lesion is rarely seen in childhood and most cases have been 
reported in women of childbearing age. Prior to the use of synthetic 
gonadal steroids in 1960, this entity was rarely recognized s o Since 
that time reports of liver cell adenoma have become more frequent, 
especially in the United States, where such steroid usage was first 
introduced and the initial steroid concentrations were higher than 
in the more recent preparations. It has also been reported in as 
FIG 27. 
Multi ple 'lepat ic adenomas. Numerous lesions of irregular dimensions with focal hemor-
rhag iC necrosIs (lower nght) . 
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many as half the patients with type I glycogen storage disease,51 in 
familial diabetes,52 and in secondary hemachromatosis. 
It usually occurs as a single lesion in an otherwise normal liver, 
but cases of mUltiple adenomas (Fig 27) have been described.5 3 The 
lesions may vary in size, most being between 5 and 15 cm in major 
dimension, and they are soft, well circumscribed, extremely vascu-
lar, and tan, red, or yellow in color. Areas of hemorrhage, necrosis, 
and scar tissue are frequent, and the overall gross appearance may 
closely resemble a solitary mass of hepatocellular carcinoma. Histo-
logically the lesion consists of hepatocytes arranged in two to three 
cell plates separated by slit-like sinusoidal spaces vvithout evidence 
of portal structures (Fig 28). Importantly, the reticulin framework is 
retained and closely resembles that of normal lobules, which aids in 
its distinction from hepatocellular carcinoma, which rarely if ever 
produces a normal reticulin pattern. The individual hepatocytes are 
larger than normal, with uniform nuclei and pink granular or clear 
cytoplasm. Large thin-walled vessels are frequent, and when throm-
bosed they may be associated vvith areas of infarction or hemor-
rhage. 
Q--Fetoprotein is not demonstrable in tumor tissue nor in the se-
rum of patients with these lesions 5 4 Q--I-Antitrypsin globules may be 
FIG 28. 
Hepatic adenoma. Narrow trabecular pattern of hepatocytes with vascular channels 
loosely separated from normal liver tissue (lower left) shows dark portal triads Hematoxy-
lin-eosin; x20. 
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present-a nonspecific finding noted also in malignant hepatocellu-
lar neoplasms. No evjdence of vascular invasion is seen. On rare oc-
casion liver cell dysplasia is present, and its significance remains un-
known . 
Focal Nodular Hyperplasia 
Focal nodular hyperplasia (FNH) occurs at any age but is most fre-
quent between the years of 20 and 45. It is more common in women 
than in men. There is increasing evjdence that FNH is probably un-
related etiologically to synthetic sex steroid usage ; however, it has 
been suggested that these drugs may facilitate the tumors' growth. 
The lesion is usually round, solitary, and less than 5 cm in maxi-
mum dimension, occurring in an otherwise normal liver. Larger (15-
cm or greater) lesions are rare and may be pedunculated. Histologi-
cally the lesion consists of normal appearing hepatocytes arranged 
irregularly into nodules, which are devoid of an acinar arrangement. 
There is a central or eccentric stellate scar vvith radiating fibrous 
septae containing proliferating bile ducts , inflammatory cell infil-
trates, and large, irregularly thick-walled venous and arterial chan-
nels (Figs 29 and 30). 
This lesion has been described in association vvith and has even 
been proposed as the benign counterpart of the fibrolamellar variant 
of hepatocellular carcinoma ss To date only 5 (4%) of 128 such cases 
FIG 29. 
Foca l nodu lar hyperplasia . Segment of lesion with central white scar. The contiguous liver 
is norm I. 
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FIG 30. 
Focal nodular hyperplas ia . Irregu lar nodules of mature hepatocytes separated by irreg ular 
bands of fib rosis containing irregularly sized vascula r channels and chronic inflammatory 
cells . Hematoxy lin-eosin ; x 20. 
have shown the presence of focal nodular hyperplasia in the same 
liver as the malignant tumor 5 4 
Mesenchymal Hamartoma 
This lesion is second in incidence only to infantile hemangioen-
dothelioma as a benign liver tumor in pediatric patients 56 In a re-
cent study of 48 cases of benign tumors from the Children 's Hospital 
of Los AngelesS 7 14 (29%) were mesenchymal hamartomas while 29 
(60% ) we\'e vascular in nature. It is almost exclusively a tumor of in -
fants and very young children) most occurring before the age of 12 
months. It is twice as common in males as females . We are aware of 
only 3 cases occurring in adults 5 B - 6 0 
Grossly ) they are well-circumscribed) soft lesions that are fluctuant 
and cystic since they contain fluid or gelatinous material (Fig 31). In 
some cases the large number of cysts suggest a multilocul ar cyst. 
Histologically these lesions are composed of edematous primitive 
connective tissue with multiple cysts) irregula rly dila ted tortuous 
bile ducts) and numerous blood and dila ted lympha tic channels.6 1 
The connective tissues contain elongated spindle and stellate cells 
Curr Probl Surg, May 1989 325 
FIG 31. 
Mesenchymal hamartoma. Well-circumscribed mucoid-appearing lesion with central white 
scar !Issue. 
in a rich vasc ular background w ith large amounts of acid muco-
polysaccharide, and valying d egrees of chronic inflammatOIY cells . 
Vascular th rombosis with areas of infarction and hemorrhage may 
occur. Occasion al islands of hepa tocytes and extramedullary he-
matop oiesis are present. Mitoses are not seen, and neither recur-
rence following surgical resection nor malignant change has been 
reported. 
Congenital Cyst 
These may arise anywhere throughout the bilialY tract, be single 
or multiple, and have congenital, traumatic, inflammatory parasitic, 
or neoplastic origins . The congenital or developmental cysts may be 
unilocu lar (solitary) or multiple (polycysticl-when they are usually 
associated vvith adult polycystic disease elsewhere (e.g., kidney). 
These cysts are usually lined by a flattened cuboidal epithelium . 
Other variants of congenital multiple cysts range from the common 
von Myenberg complexes (small bile duct dilations), which may re-
semble multiple small metastatic deposits on the capsular surface of 
the liver, to the rare entities, Caroli's disease (Fig 32) and congenital 
hepatic fibrosis, which are characterized by a spectrum of dilated 
large bile ducts with associated bile inspissation) intraductal lithia-
sis, or surrounding fibrosis (Fig 33l. 
Cysts have also been noted to arise in the hepatic hilum and ap-
pear to represent dilations of the periductal glands possibly due to 
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FIG 32. 
Caroli's disease. Marked fibrosis of focal ly dilated intrahepatic biliary tree wi th numerous 
pigment stones and prominent biliary ci rrhosis. 
FIG 33. 
Caroli's disease. Dilated bile duct with partially denuded epithelial lining su rrounded by 
secondary organized fib rosis and chronic inflammation. Hematoxylin-eosin; x 50. 
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FIG 34. 
Squamous cys t of liver. Cyst is lined by mature squamous epi thelium with sub jacent fi-
brous wall separating It from liver parenct1yma. Hematoxylin-eosin ; x 50. 
inflammation . In these situations the cysts may be lined by noncili-
ated cuboidal to columnar epithelium. Metaplastic (Fig 34) and neo-
plastic transformation of these cystic lesions occurs and both cysta-
denocarcinoma as well as squamous carcinoma (Fig 35) have been 
described as arising from these congenital cysts H2 - 6 5 
Hydatid (Echinococcal) Cyst 
Echinococcosis is of worldwide d istribution and may affect most 
organs within the body, the liver be ing the most frequently involved. 
Hydatid cyst fo rmation in the liver is attributable to migration of the 
embryo of the larval form of Echinococcus granuLosus from the duo-
denum to the liver via the bloodstream. Enclosed within the host's 
dense fibrous capsule, the cyst waJl consists of an outer l-mm thick! 
deathly white, laminated, anuclear membrane surrounding an inner 
germinal layer that gives origin to brood capsules that form proto-
scolices. Each scolex has suckers and hooklets , the latter being bire-
fringent and easily demonstrable with acid-fast stains. The cyst en-
larges, providing numerous evaginations of the wall with the forma-
tion of mUltiple generations of daughter cysts. As the brood capsules 
are shed into the cyst lumen they form a fine granular sediment 
known as hydatid sand. 
The cysts are usually single but may be multiple. They usually oc-
cur in the right lobe, a feature that lends to their resectability. They 
may be large and even pedunculated from the liver substance, fea-
tures that may increase the possibility of cyst rupture with conse-
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FIG 35. 
Squamous cell carcinoma of liver. Irregular sheets of squamous epithelium with focal ker-
atin pearl forma tion . Hematoxylin-eosin ; x 125. 
quent severe, occasionally fatal, allergic reaction . Secondary infec-
tion may also cause rupture of the cyst into the biliary tree with chol-
angitis (Fig 36) or into the peritoneal cavity with extensive seeding 
and diffuse intraperitoneal cyst formation. The cyst wall may 
calcify, a feature of importance in the radiologic diagnosis of these 
lesions. 
The preoperative diagnosis of hydatid cyst has been greatly facili-
tated by computerized tomography and ultrasonography. Specifi-
cally, liver biopsy is contraindicated in any patient in whom the di-
agnosis of hydatid disease is being considered because of the possi-
bility of cyst content leakage vvith resultant anaphylactic reaction. 
Sclerosing cholangitis developing after surgical therapy for hydatid 
cyst has been reported. 
Echinococcus multilocularis, which rarely infects humans, evokes 
no outer cyst wall, and as a result numerous small cysts for'm 
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FIG 36. 
Echinococcal cyst. Large cyst at right with contiguous smaller cysts embedded in fibrous 
tissue reflecting prior rupture of cyst. 
throughout the entire liver. Many of these cysts, when they lose via-
bility, evoke a foreign body giant cell reaction. 
MALIGNANT LESIONS 
Metastatic Tumors 
Metastatic neoplasms are by far the most common hepatic malig-
nancy, representing more than 95% of such neoplasms in autopsy 
series.66 The most common primary sites are the pancreaticobiliary 
tree, breast, colon, skin, stomach, and lung. However, in the Western 
world metastatic carcinomas are most likely to have had their origin 
in lung, colon, breast, and pancreas because of the greater preva-
lence of these lesions in this geographic location. 
The select subgroup of patients who are offered hepatic resection 
for metastatic disease have no metastases in other organs. The num-
ber and location of premetastatic lesions within the liver as well as 
the inherent biological behavior of the specific histologic tumor type 
determine resection. Pickren and associates66 reported that malig-
nancies arising in organs drained by the portal vein are more likely 
to show hepatic metastases and also are more likely to have me-
tastases confined to the liver. These facts are among those contrib-
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uting to the current emphasis on resecting colonic carcinoma me-
tastases to the liver. 
In our institution the isolated colonic metastasis in one or other 
lobe of the liver has been the most frequently resected metastatic le-
sion with neuroendocrine tumors a very distant second . Of the 153 
metastatic carcinomas in our series 118 (77%) had primary origin in 
the colon, which contrasts with a relative frequency of 56% in au-
topsy series 66, 67 
The reasons for this difference are many. In patients with malig-
nant disease who are evaluated at autopsy, as compared to those 
having liver resection, there is (1) a longer time for the development 
of liver metastases, (2 ) an increased likelihood of multiple liver me-
tastases, (3) an increased period of time during which various types 
of carcinoma, including those vvith inherently poor prognoses could 
spread to the liver, and (4) the possibility of vital structure involve-
ment that precludes any form of partial resection. For such reasons 
the resectability rates in patients with hepatic metastases are no 
greater than 25% to 30% .68. 69 There are valid reasons why select pa-
tients with metastatic neuroendocrine carcinoma/malignant carci-
noid tumors may live for many years. Patients with colon carcinoma 
metastatic to a specific segment of the liver (Fig 37) have a long-term 
sUivival follovving resection .70- 72 
Hepatocellular Carcinoma 
This is the most common primary epithelial hepatic malignancy 
and represents up to 85% of such lesions.67 There is a striking geo-
graphic variation in its distribution. It is relatively uncommon in the 
Western world but very frequent in South Africa, China, Japan, and 
Southeast Asia. The age of onset appears to be earlier (third to fifth 
decades ) in areas of high incidence, compared with geographic ar-
eas of low incidence. There is a striking male predominance, espe-
cially in high-incidence areas. 
The tumor may come to recognition because of the identification 
of a known etiologic factor. The theme common to most of these 
neoplasms is cirrhosis, attributable to a variety of chronic hepatic in-
juries, including viral hepatitis/ 3 alcohol ingestion, and metabolic 
derangements.74 Also, the consumption of aflatoxin, anabolic-andro-
genic steroids and possibly oral contraceptive steroids 75 has been 
suggested as being causative. 
Tumor markers are used to diagnose hepatocellular carcinoma,76 
and improvements in the radioimmunoassay methods allow the de-
tection of increased serum a -fetoprotein levels in 80% of patients 
with hepatocellular carcinoma.77 
Other diseases such as viral hepatitis, yolk sac tumors, gastric car-
cinoma, and pancreatic carcinoma,76, 78, 79 as well as testicular ter-
atomas, may be associated with increased levels of serum a-fetopro-
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FIG 37. 
Metastatic colon carcinoma. Two separate lesions, both abutting capsule. The resecting 
margin (be/ow) is uninvolved by tumor 
tein . The value of other serum tumor markers in the diagnosis of he-
patocellular carcinoma is being evaluated.8 0 
Grossly the liver is enlarged and may be cirrhotic. The tumor is 
soft necrotic, hemorrhagic, and focally bile stained. It occurs as a lo-
calized nodular mass, or it may be massive and involve an entire 
lobe (Fig 38J. Rarely it occurs as a diffuse constellation of small nod-
ules throughout the entire livers1 Another classification has been 
proposed by Okuda and associates8 2 in a study of cases from Japan, 
South Africa, and the United States . They grouped cases into ex-
panding, spreading, multifocal , and indeterminate categories and 
noted that the "encapsulated" variety was common in Japan but rare 
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FIG 38. 
Hepatocellular carc inoma Large irregularly nodular tumor with multiple areas of hemor-
rhage, necrosis, cys tiC degenera tion, and fibrosis. 
in the United States and South Africa. Invasion of the portal vein, he-
patic vein, and bile duct may be noted, with occasional extension 
into the inferior vena cava and the right atrium 83 
Microscopically this tumor may show a variety of histologic pat-
terns occurring in the same tumor. The most frequent is that of tra-
becular growth, in which irregularly sized sheets of malignant 11epa-
tocytes are separated from one another by sinusoidal type spaces 
lined by endothelial cells. The stromal component, other than that 
attributable to scar, is minimal, hence their soft gross appearance . 
Bile canaliculi may be seen on routine stains and confir'med immu-
nohistochemically.84 The presence of bile within tumor cells is 
pathognomonic of this tumor. Vascular invasion is extremely fre-
quent. The diminished to absent reticulin framework seen in this tu-
mor is not evident in normal liver or benign hepatocellular lesions 
and is very valuable in the differential diagnosis of these hepatic 1e-
sions 85 
The malignant hepatocytes have defined cell borders, granular 
pink cytoplasm, and round to oval nuclei with prominent nucleoli . 
Clear cells (attributable to their fat or glycogen content) and 
pseudoglandular or adenoid areas are frequent (Figs 39 and 40). The 
degree of pleomOI'Phism may be minimal or marked, with bizarre 
atypical giant cells and spindle cells (Fig 41l. These various his to-
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FIG 39. 
Hepatocellular carcinoma. clear cell type . This lesion must be differentiated from olher 
clear cell carcinomas, especially renal and adrenal. Hematoxylin-eosin ; x 125. 
FIG 40. 
Hepatocellular ca rcinoma Two types of differentiation are present. The lower right shows 
trabecular and pseudoglandular (adenoid); the upper lefl shows clear cell differentialion 
Hemaloxylin-eosin; x 125 
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FIG 41. 
Hepatocel lular carcinoma, giant cell type. Hematoxylin-eosin; x 125. 
logic patterns of hepatocellular carcinoma expand its dif"ferential di-
agnosis to include spindle cell neoplasms of soft tissue, whether pri-
mary or metastatic in the liver, as well as renal and adrenal carcino-
mas. 
The identification of typical areas of hepatocellular carcinoma, the 
presence of immunohistochemically detectable Cl-fetoprotein within 
tumor cells , and the elevated levels of this protein in the serum re-
main the best means of establishing the diagnosis of hepatocellular 
carcinoma. Immunohistochemical studies have shown the nonspe-
cific presence of a variety of other antigenic components "'ri thin ma-
lignant hepatocytes. Most of these antigens except for those of hep-
atitis B virus are equally commonly expressed in the ordinary and 
fibrolamell ar variants of hepatocellular carcinoma.5 4 Hepatitis B viral 
surface and core antigens are specifically but not commonly en-
countered in the ordinary variant and do not appear to be signifi-
cantly expressed in the fibrolamellar variant of hepatocellular carci-
noma.54 
Other histologic features of hepatocellular carcinoma are the pres-
ence of intracellular Mallory's hyaline, hyaline globules, fat, glyco-
gen, and a ground glass cellular appearance. With the exception of 
Mallory 's hyaline, these features are nonspecific and can be seen in 
a variety of other tumors. 
There are other histologic variants of hepatocellular carcinoma. 
They include the fibrolamellar and sclerosing variants, both of which 
have been recognized most frequently in the United States, and the 
so-called mixed hepatocellular cholangiocarcinoma, which is best 
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considered as a hepatocellular carcinoma with focal areas of mucin 
producing adenocarcinoma and behaves as the former (Fig 42). In 
much the same manner some hepatocellular carcinomas may show 
focal neuroendocrine differentiation, but too few of these lesions 
have been described to allow assessment of their behavior. 
Areas of either large cell or small cell dysplasia appear to be asso-
ciated \lvith an increased risk of developing hepatocellular carci-
noma, but the relationship is not considered established. 
Hepatocellular carcinoma commonly metastasizes to lung, re-
gional lymph nodes, and contiguous organs but rarely to other or-
gans . 
Fibrolamellar Hepatocellular Carcinoma 
This recently popularized variant of hepatocellular carcinomal!6.87 
was first recognized by Edmondson in 1956 . Since then more than 
150 cases have been reported 8b This variant has been noted in the 
United States and Europe but seems to be rare elsevvhere. 
Fibrolamellar hepatocellular carcinoma has many eponyms, such 
as eOSinophilic hepatocellular carr.inoma with lamellar fibrosis, po-
lygonal cell type with fibrous strolIla, and fibrolamellar oncocytic he-
patoma. The tumor is distinguished from the ordinary variant of he-
patocellular carcinoma by its frequent occurrence in young patients, 
the lack of male predominance, characteristic morphological find-
FIG 42. 
Hepatocellular carcinoma. Two types of differentiation are present: the lower right shows 
trabecular tumor, the upper left shows focal glandular differentiation. Hematoxylln·eosln ; 
x50 
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ings in which large eosinophilic (oncocytic) hepatocytes lie in a 
lamellated fibrous stroma, the lack of a significant association with 
cirrhosis, and its favorable prognosis. 
The relationship between this tumor and oral contraceptive use 
remains controversial. In a recent study from this institution ele-
vated serum a-fetoprotein levels and demonstrable immunohis-
tochemicaJ localization of a-fetoprotein in tumor cells was noted in 
4 (21%) of 19 cases, a lower incidence than noted "'lith the more 
common variant of hepatocellular carcinoma. Elevated vitamin B12 
binding capacity levels have been claimed to be specific for this tu-
mor88 
Grossly the tumor is a solitary, well-circumscribed, finn mass of 
variable size, with a nodular gray, green, white color on cut surface 
and a central stellate scar reminiscent of focal nodular hyperplasia 
(Fig 43). 
Microscopically the tumor is composed of parvicellular hyalinjzed 
laminated collagen bundles which separate irregularly sized groups 
of eosinophilic, granular hepatocytes (Fig 44) (which show abundant 
mitochondria ultrastructurally) . The cytoplasm also shows abundant 
hyaJine globules, bile, copper and copper-associated protein, fibrin-
ogen, C-reactive protein, ferritin and al-antitrypsinS4.89 The nuclei 
FIG 43. 
Fibrolamellar heptocellular carcinoma Large (20-cm) lumor arising in normal liver (top left) 
with extensive radiating scar formation (center right) . 
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FIG 44. 
Fibrolamellar hepatocellular carc inoma. Large oncocytic hepatocytes in irregular cords 
separated by acel lular lamellated collagen Tr ichrome; x 125. 
are round, oval and vesicular with prominent nucleoli. Occasionally 
marked nuclear hyperchromatism and pleomorphism are seen. 
This tumor may have foci of ordinary variant hepatocellular carci-
noma but must also be distinguished grossly and microscopically 
from other tumors such as focal nodular hyperplasia, sclerosing he-
patocellular carcinoma, and metastatic neuroendocrine carci-
noma 9 0 
Fibrolamellar hepatocellular carcinoma is more amenable to re-
section than the o rdinary variant, and the results of such therapy 
are m uch m ore favorable even when known metastases are present 
at the time of surgery.81 
Neuroendocrine Carcinoma 
These tumors have been reported both in children and adults.92 . 83 
Some show apparent divergent differentiation patterns manifesting 
hepatocellular or cholangiocarcinomatous patterns, or both, to-
gether with a neuroendocrine pattern of malignancy94 It is difficult 
to prove the primary hepatiC origin of such tumors, and good prac-
tice dictates that such an origin be ascribed only after exhaustive 
search has excluded an extrahepatic source for the tumor. 
This is an important entity to differentiate from hepatocellular car-
cinoma in particular. They frequently are firm white to yellow on 
gross appearance and they show cellular monotony with a frequent 
palisading pattern at the periphery of tumor cell trabeculae histolog-
ically (Fig 45). Their tlLle nature is readily confirmed by positive 
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FIG 45. 
Neuroendocrine carcinoma. Note pa lisading fl brovascular stroma and un iform appear-
ance of epithelial cells Hematoxyli n-eosin; x 125. 
grimeJius and chromogranin staining as well as by the characteristic 
appearances of neurosecretOIY granules on ultrastructural examina-
tion, 
Cho/angiocarcinoma 
This tumor is extremely rare in childhood . It occurs most fre-
quently in patients who are older than 50 years) and it has equal sex 
distribution. The tumor may occur anywhere in the biliary tree) and 
its presentation reflects the specific site and extent of tumor occur-
rence, Intrahepatic tumors are usually peripheral and represent less 
than 25% of all primary malignant liver tumors.9 5 Classically these 
tumors are rock hard and gray-white with irregular infil trating edges 
and mUltiple satellite nodules, Vascular invasion is present in less 
than 20 % of cases) but 70% to 75% of patients have metastases to re-
gional nodes, lung) or bone, The major difficulty \vith this tumor is 
its pathologic distinction from metastatic adenocarcinoma arising in 
the pancreas) biliary tract) and other organs, 
The diagnosis of primary cholangiocarcinoma can only be estab-
lished after other primary sources have been excluded, A sometimes 
helpful feature is the presence of intraductal in situ carcinoma. 
However) we have seen partial replacement of a bile duct by meta-
static colon adenocarcinoma which closely resembled the pattern 
of in situ cholangiocarc inoma. Inflammatory reactive epithelial 
changes) including those seen with sclerosing cholangitis may be 
confused with cholangiocarcinoma. 
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Cholangiocarcinoma has been associated with a variety of etio-
logic factors such as thorotrast,96 sclerosing cholangitis associated 
with inflammatory bowel disease,97,88 choledochal cysts, and, in ap-
propriate geographic regions, Clonorchis infestation, Patients with 
chronic ulcerative colitis have a significantly greater risk of develop-
ing cholangiocarcinoma, usually at a younger age than these tumors 
most often occur, 
Extrahepatic tumors are more frequent than intrahepatic lesions, 
but nevertheless account for less than 2% of surgical operations on 
the bile duct. We include the hilar (KJatskin) tumor with extrahe-
patic tumors, even though many of these tumors are "hidden" within 
the liver substance, because its presentation is similar to that occur-
ing with the more distal biliary tract tumors,99 
The recognized etiologic factors are similar to those seen with in-
trahepatic cholangiocarcinoma. If cirrhosis is present it is usually a 
biliary cirrhosis secondary to obstruction, Grossly the tumor may ap-
pear as a gray-pink, friable, intraductal papillary lesion or more fre-
quently as a sclerosing white, nodular lesion extending along varying 
lengths of the thickened duct wall with consequent narrowing of the 
duct lumen, The tumor frequently extends into adjacent soft tissue 
and may surround or invade the portal vein or hepatic artery, 
Some of the major problems with the tumor relate to (1) the diffi-
culty in determining its extent both grossly and microscopically, (2) 
recognition that the disease may be multicentric throughout the bil-
iary tree, and (3) the difficulty in distinguishing betvveen inf1amma-
tory regenerative epithelial changes and true neoplasia on frozen 
section examination. The latter is probably one of the most difficult 
areas of surgical pathology and requires maximal cooperation and 
understanding between pathologist and surgeon , 
Microscopically the lesion is a mUCin-producing, vvell-differenti-
ated adenocarcinoma wo Rarely, squamous cell differentiation is en-
countered, The superficial regions of the tumor may show papillary 
features and the deeper regions may manifest poorly differentiated 
tumor. Cytologic examination of aspirates or duct scrapings has 
been of significant diagnostic value.101 In association with its exten-
sive desmoplastic reaction (Fig 46 ) the tumor shows the helpful diag-
nostic features of neural, venous, and lymphatic invasion as well as ar-
eas of necrosis . Areas of in situ carcinoma (Fig 47), dysplasia and meta-
plasia , intestinal as well as antral types, are frequently noted in areas 
contiguous to the carcinoma. Metastases are noted in approximately 
50% of cases and are usually limited to regional lymph nodes and 
the liver, Involvement of more distant organs is rare, 
Hepatoblastoma 
This malignant tumor occurs in the first few years of life and is 
slightly more frequent in males102 Jt usually presents as an upper 
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FIG 46. 
Inf iltrating cholangiocarcinoma. Note marked desmoplasia and Irregular gland formation. 
Hernatoxylin-eosin; x 125. 
FIG 47. 
Cholangiocarcinoma, in situ and infiltrating. Note the normal appearance of left side of 
largest duct with abrupt change to neoplastic epithelium on the right. The infiltrating glan· 
dular component with prominent desmoplasia is evident. Hematoxylin-eosin; x 125. 
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abdominal mass. Grossly the tumor appears as a well-circum-
scribed, lobulated, solitary, tan mass frequently in. the right lobe of 
an otherwise normal Iiver102. 103 These features contribute to the rel-
ative ease of hepatic resection of this tumor; however, the surgeon 
should take a vvide margin because microscopic intravascular 
spread beyond the grossly discernible tumor mass is not infrequent. 
Microscopically this tumor has been recognized as a pure epithe-
lial or as a mixed mesenchymal and epithelial type of malignancy.lo2 
The epithelial elements are fetal or embryonal cells, or both (Fig 48). 
The fetal ce lls are smaller than normal hepatocytes with minimal 
pleomorprism, rare mitoses, and clear or amphophilic cytoplasm. 
The cells are arranged in narrow cords or broad sheets. The embry-
onal cells occur in sheets and trabeculae and show larger, rnore 
pleomorphic n uclei, more frequent mitoses, and less cytoplasm, 
which gives the impression of a darker staining, more densely 
packed cell population. Occasional ductular differentiation is not-
ed, 1114. 1M K~ and extramedullary hematopoiesis is almost always 
present. 
The mesenchymal elements occur in up to 50% of hepatoblasto-
mas 102,103 an d are small immature sp indle cells, occurring in imme-
diate relationsh.ip to the epithelial elements. Osteoid formation may 
be seen within the immature stromal or epithelial tissues; m ore 
rarely, cartil aginous or rhabdomyoblastic stromal differentiation oc-
cur.103 . J05 
FIG 48. 
Hepatoblastoma. The darker embryonat cells are present at top left; the paler fetal cells 
are present throughout the remainder of the pic ture. Hematoxylin-eosin; x 125. 
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The importance of resection is reflected in the fact that cure may 
be achieved in 30% to 50% of patients if the tumor is totally resect-
ed 106 • ] 0 7 In addition, cases in which the tumor was initially consid-
ered unresectable have been rendered resectable by preoperative che-
motherapy?08, 109 Unfavorable features associated with poor progno-
sis are the presence of multiple tumors or nodal metastases.uo Pro-
vided it is completely resectable, the size of the primary tumor is not 
of prognostic significance A favorable prognostic feature is fetal dif-
ferentiation in contrast to the poor prognosis associated with em-
bryonal or undifferentiated histologic types .103 
Most hepatoblastomas, especially those showing histologic differ-
entiation, will manifest increased serum levels of a-fetoprotein . 
Other than hepatocellular carcinoma the only other primary hepatic 
tumors to be associated with markedly increased levels of a-fetopro-
tein are the mesenchymal hamartoma11 l and rarely, yolk sac carci-
noma. l1Z 
SARCOMAS 
These are much less common than carcinoma, whether they oc-
cur as primary or metastatic lesions113 The primary source of meta-
static sarcoma in the liver is usually obvious. Of the primary tumors, 
angiosarcoma is the most common. Specific sarcomata such as leio-
myosarcoma114 appear to lend themselves more readily than others 
to hepatic resection (Fig 49). In our series almost half of both the pri-
FIG 49. 
Leiomyosarcoma of liver. The top left corner shows well-differentiated tumor; the remain-
der is undifferentiated . Hematoxylin-eosin; x 125. 
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mary and the metastatic sarcomas were of smooth muscle origin. Al-
though sarcomas of the liver are exceedingly rare , Chen 114 described 
15 cases of primaly leiomyosarcoma of the liver. Other rep0I1s of fi-
brosarcoma115 and malignant fibrous histiocytoma 116 of the liver 
have also appeared . 
Metastatic leiomyosarcoma to the liver (Fig 50) is most frequently 
of uterine, gastric, or intestinal origin. Sarcomas aIlsing elsewhere 
usually spread first to lung and subsequently to liver.117 
Angiosarcoma 
This tumor is the most com mon mesenchymal neoplasm of the 
liver and occurs at all ages, vvith a m ean age in the sixth decade 1l8 It 
is more common in men and has a dismal prognOSis-affected pa-
tients rarely sUlvive beyond 2 years. The incidence of this tumor ap-
pears to have increased in recent decades, reflecting its recognized 
association w ith knovvn e tiologic agents such as thorotrast, vinyl 
chloride, arsenic, and anabolic steroids l1tl . 119 Patients vvith such ex-
posure have latent periods in excess of 20 years before the tumor is 
apparent. They also have associated hepatiC fibrosis. 
Grossly the tumor is most frequently multicentric and involves 
both lobes. The tumor nodules are of varying size, are irregular in 
outline and ap pear spongy. The contiguous liver may be fibrotic and 
thorotrast deposits may be noted in the subcapsular region and in 
regional lymph nodes. 
FIG 50. 
Metastatic leiomyosarcoma of colon . Multiple irregular tumor nodules without spec ific dis-
tinguishing features. The resection margin (lower right) is not involved by tumor. 
344 Curr Probl Surg, May 1989 
Microscopically the liver is composed of pleomorphic bizarre en-
dothelial cells (Fig 51) which stain positively for factor VIII-related 
antigen (Table 1J. There are valying numbers of mitoses. Sinusoidal 
dilatation with atrophy of hepatocytes associated with nodules of 
spindle and/or epithelioid cells separated by a delicate reticulin 
framework may be seen. There is little collagenous stroma, areas of 
hemorrhage and necrosis are common, and vascular invasion (portal 
and hepatic vein) is frequent. 
Metastases occur to the lungs, bones, lymph nodes, spleen, and 
adrenal gland, but most deaths are attributable to liver failure or 
hemorrhagic complications. The median sUlvival is less than 6 
months .11Il To date surgery and chemotherapy have had little to of-
fer. 
Epithelioid Hemangioendothelioma 
This malignant vascular tumor has been recently described in soft 
tissue/2o lung/21 and liver.122.123 
Grossly the lesion consisted of multifocal round to oval, white, 
fil'm nodules with hyperemic borders, which range in size up to 5.0 
cm and are irregularly distributed throughout the entire liver (Fig 
52). The nodules often extend to the capsule. The liver parenchyma 
is normal unless obstruction with secondary biliary cirrhosis occurs. 
Similar lesions may be seen in regional lymph nodes and in distant 
FIG 51. 
Angiosarcoma of liver. Irregular anastomosing channels lined by pleomorphic endothelial 
cells that also infiltrate into sinusoids between liver plates. Darker material at top lett is 
thorot rast. Hematoxylin-eosin; x 125. 
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FIG 52. 
Epithelioid hemangioendothelioma. Multiple discrete nodules of varying size with surface 
umbilication occurring in otherwise normal liver. 
organs. Microscopically the nodules show a parvicellular myxoid fi-
brous center with a relatively hypercellular periphery (Fig 53) . The 
cells are of two types ; dendritic and epithelial, the latter growing 
preferentially in vascular spaces. 
Many cells showed vacuoles that are vascular spaces. The growth 
pattern appears centrifugal, with tumor cell extension along 
the portal vein and sinusoids, and hepatiC venules in particular. Be-
cause of these histologic features this tumor has been misinter-
preted in the liver as cholangiocarcinoma, sclerosing hepatocellu-
lar carcinoma, sclerosing angiosarcoma, or metastatic adenocarci-
noma. 
Immunohistochemically the tumor cells manifest factor VIII re-
lated antigen consistent with its vascular nature (see Table 1). 
Studies from this laboratory124 have demonstrated the presence of 
von Willebrand factor antigen in tumors that have not manifested 
late recurrence, but not in those that have recurred extrahepatic-
ally. 
The prognosis of patients with this tumor is unpredictable . It is 
not amenable to partial hepatic resection, but has been successfully 
treated with total hepatectomy and liver transplantation despite the 
presence of recognized extrahepatic tumor nodules.125 
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FIG 53. 
Epithelioid hemangioendothelioma. Irregular centriacinar extension of tumor around peri-
portal zones (top central) with less cellular tumor in deeper regions (bottom right). Hema-
toxylin-eosin: x50. 
Embryonal Rhabdomyosarcoma 
This tumor develops in the extrahepatic biliary tree and is the most 
common bile duct tumor in children. It rarely occurs in adults.126.127 
No sex predilection has been noted. 
Grossly the tumor shows a white cut surface) thickening of the bile 
duct wall with narrowing of the lumen and projection of gelatinous 
grapelike (botryoid) masses into the duct lumen. These changes 
cause dilatation of the proximal biliary tree and green discoloration 
of the liver due to cholestasis. 
Histologically) the tumor is covered by flattened biliary epithelium 
that may be ulcerated. The superficial subepithelial region of the tu-
mor is densely cellular and is called the "cambium layer." The 
deeper areas of the tumor are less cellular and show a prominent 
myxoid stroma. 
The tumor cells are primitive and round) spindle or racquet 
shaped with dense cytoplasmic eosinophilia indicative of rhabdo-
myoblasts. Cross striations are difficult to visualize and mitoses are 
of varying frequency. 
Immunohistochemically the tumor cells may manifest myoglobin) 
myosin) desmin) or vimentin (see Table 1J. The former is the most 
valuable marker) having been seen in the majority of tumors.128.129 
The ultrastructural finding within some tumor cells of alternating 
actin and myosin filaments) occasionally showing a banding pattern) 
is also of diagnostic value.127.130 
348 Curr Probl Surg, May 1989 
Embryonal Sarcoma 
This tumor is most frequently seen in children between 6 and 10 
years of age.131 It rarely occurs in adults.132,133 
The tumor is usually single, circumscribed, large, globular, fluctu-
ant and may contain gelatinous, cystic, necrotic or hemorrhagic ar-
eas. Histologically it is composed of spindle and stellate cells, which 
are occasionally markedly atypical and multinucleate, and rest in a 
myxoid stroma. The tumor cells frequently show D-PAS-positive 
globules that stain for a 1-antitlypsin (see Table 1). It is possible that 
they may also stain for other cell products such as fibrinogen if they 
resemble the globules seen in other liver tumors.54 a-Fetoprotein 
has not been demonstrated in these globules to date.134 No diver-
gent mesenchymal differentiation has been noted. Irregularly dilated 
bile duct elements may be seen at the tumor peripheIY and proba-
bly represent entrapped tissue, but no true malignant epithelial ele-
ments are present?31 Patients with these tumors may sUivive follow-
ing complete resection of the tumor; otherwise sUivival beyond 1 
year is not commonly seen. It is of interest that in a recent series of 
patients with embryonal sarcoma and embryonal rhabdomyosar-
coma the shortest survivals were in those who did not undergo tu-
mor resection.135 
OUR EXPERIENCE WITH HEPATIC RESECTION 
Our interest in hepatic resection started with the referral for liver 
transplantation of patients whose hepatic lesions were thought to be 
too extensive for subtotal hepatectomy (hepatic resection) and who 
would require total hepatectomy with liver replacement (orthotopic 
liver transplantation). Many of these tumors could be removed only 
by most extensive resections, such as right and left trisegmentec-
tomy. This is the reason why more than one third of our patients 
were treated with trisegmentectomies, and our experience may not 
reflect the overall picture of surgery for hepatic tumors. Neverthe-
less, our aggressive approach to various hepatic lesions is worth-
while reporting because of the low operative mortality and morbid-
ity, and the satisfactory results. Portions of our experience have been 
reported earlier.30- 32,135-141 
CASE MATERIAL 
During a 25-year period, from October 1964 to September 1988, 473 
patients undeIWent hepatic resection at the University of Colorado 
Health Sciences Center (1964 to 1980) and the University Health Cen-
ter of Pittsburgh (1981 to 1988). The number of hepatic resections 
has increased sharply through the years (Table 2), and 500 patients 
will be included in our series by the end of 1988. 
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TABLE 2. 
Hepatic Resection by 5-Year Period and Indication 
No. of llenign Primary Secondary 
Years Patients Lesion Malignancy Malignancy 
(1964)'-1970 6 4 2 0 
1971-1975 25 10 10 5 
1976-1980 77 32 17 28 
1980-1985 181 87 43 51 
1986-(1987)t 184 64 51 69 
Total 473 197 123 153 
I' = Starts in October. 
It = Ends in September. 
Ages of the patients ranged from 11 months to 81 years. Twenty-
seven of the 473 patients were younger than 18 years, and 24 of 
these 27 were younger than 12 years. 
Indications for hepatic resection on 473 patients are listed in Ta-
ble 2. There were 197 patients with benign hepatic lesions who un-
derwent hepatic resection for therapeutic purposes or because ma-
lignancy could not be ruled out preoperatively. The remaining 276 
patients had hepatic resection for malignant diseases, of which 123 
tumors were primary to the liver and 153 were metastases to the 
liver from various origins (see Table 2). 
The kinds and numbers of hepatic resections for benign lesions, 
primary hepatic malignancy and metastatic tumors are summarized 
in Table 3, including the operative mortality of each group. As men-
tioned previously, extended right and left lobectomy were classified 
as right and left lobectomy in this report. 
POSTOPERATNE MORTALITY 
Any death within a month after hepatic resection was counted as 
an operative death. Sixteen of 473 patients died within a month after 
various kinds of hepatic resection, for an overall operative mortality 
of 3.4%. Details of the operative mortality after various kinds of he-
patic resection for different indications are summarized in Tables 3 
and 4. The operative m0I1ality was 5.5% (9 of 163) after trisegment-
ectomies, 3.3% (6 of 183) after lobectomies and 0.8% (1 of 127) after 
left lateral segmentectomies and non-anatomical local resections. 
The operative mortality after hepatic resection for primary hepatic 
malignancy was considerably higher, 9.8% (12 of 123), than that after 
resection of metastatic tumors, 0% (0 of 153), and than that after re-
section of benign hepatic lesions, 2.0% (4 of 197). 
Nineteen of the 473 patients had severe cirrhosis. The operative 
mortality in these 19 patients was 37% 17 of 19). In contrast the mor-
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TABLE 4. 
Time and Cause of Operative Mortality IDeath in 1 Month)' 
Age/Sex Diagnosis 
64/F Cho langiocarcinoma 
22/F Regenerative nodule 
misdiagnosed as 
HCC 
50/M HCC in cirrhosis 
63/M HCCin 
hemochromatosis 
281M Abscess after 
trauma 
77/M HCC in cirrhosis 
S5/F Cholangiocarcinoma 
45/M HCe 
:l1/M Trauma 
52/1" NeuroendocIine 
tumor I?) 
511M Abscess after 
cholecystectomy 
36/F HCe in cirrhosis 
62/M Bile duct cancer 
71/M HCe in cin'hosis 
59/M HCC 
41/F HCC in cirrhosis 
Pl'Ocedure 
HTS 
RL 
RL 
LTS 
RTS 
Local 
LTS 
RTS 
RTS 
RTS 
RL 
RTS 
RTS 
HL 
RL 
RL 
Time of Death 
(Days) 
20 
4 
0 
7 
0 
0 
0 
6 
1 
0 
19 
0 
29 
28 
0 
20 
Cause of Death 
Hepatic failure 
Celiac axis 
thrombosis 
Postoperative 
bleeding 
Hepatic failure 
Perforation of CVP 
cathetm' into 
pericardium, 
cardiac tamponade 
Hepatic failure 
Hemon'hage 
Myocardial infarction 
Hemorrhage 
Hepatic failure 
Transplant un 6th 
day 
Arrythymia due to fat 
emboli? 
Hemon'hage 
Sepsis, multiple organ 
failure 
Hemorrhage 
Liver failure 
Liver failure 
Myocardial 
infarction 
Hemorrhage 
Liver failure 
Pneurnonia 
·RTS = right trisegmenlectomy; RL = righllohectomv; Lrs = left trisegmentectorny; Local = nonanatomical 
local excision; BCe = hepatoc~lfular c,.u'cinoma. 
tality among the 454 patients without significant cirrhosis was 2% (9 
of 454). Six of the 12 operative deaths among the patients with pri-
mary hepatic malignancy were encountered in the cirrhotic pa-
tients. 
A high operative mortality was experienced after trisegmentec-
tomy for primary malignancy (11%), after hepatic resection for 
trauma (18%) and for hepatic abscess 140% I. On the other hand, 
there was no operative death after 153 hepatic resections for meta-
static tumors. There was also no operative mortality among 109 pa-
352 Curr Probl Surg, May 1989 
tients with giant cavernous hemangioma, among 23 patients with 
liver cell adenoma, among 19 patients with focal nodular hyperpla-
sia, and among 17 patients with congenital hepatic cysts. Four 
deaths among 197 patients with benign hepatic lesions occurred 
only with trauma, abscess and pseudohepatoma (a regenerative 
nodule misdiagnosed as a hepatoma) in a cirrhotic liver. 
The circumstances of the 16 operative deaths are summarized in 
Table 4. There were 7 intraoperative deaths. Five of the 7 deaths 
were due to hemorrhage (4 in trisegmentectomy and 1 in right 
lobectomy). One patient died of myocardial infarction during a local 
excision of hepatocellular carcinoma in the cirrhotic liver. The blood 
loss was minimal during the procedure. In another patient a central 
venous catheter peiforated the right atrium, which was not recog-
nized until cardiac resuscitation. This patient died of cardiac tam-
ponade and hypovolemia. 
Four more patients died or underwent an attempt at liver trans-
plantation in the first week after resection (see Table 4). The first pa-
tient had recovered completely from anesthesia after right triseg-
mentectomy for blunt trauma and was sitting and talking to the fam-
ily, when he suddenly developed arrhythmia and died. The post-
mortem examination only revealed cardiomegaly and microscopic 
fat emboli of the heart and the lungs. The second patient died of 
postoperative bleeding and subsequent liver failure after right lobec-
tomy. In this case a large regenerative nodule in the cirrhotic liver 
was misdiagnosed as an hepatocellular carcinoma. 
The third patient with hemochromatosis died from hepatic failure 
after left trisegmentectomy for hepatocellular carcinoma. The search 
for a suitable donor was unsuccessful. The fourth patient underwent 
liver transplantation 6 days after an unwise attempt at right triseg-
mentectomy for hepatocellular carcinoma which had compromised 
the inferior vena cava just at the diaphragm. This patient died from 
multiple organ failure. The last two patients should have been 
treated by total hepatectomy and hepatic replacement as primary 
therapy. 
Five other patients died from hepatic failure within a month after 
hepatic resection. The first patient died from acute onset of hepatic 
failure due to celiac axis thrombosis 20 days after right trisegmente-
ctomy. The postmortem examination revealed a significant injUIY at 
the orifice of the celiac axis, probably caused by preoperative angiog-
raphy. The second patient had developed a large abscess in the ne-
crotic right lobe after cholecystectomy. Despite percutaneous cathe-
ter drainage, the patient had been septic and had required hemodi-
alysis for renal failure. This patient died 19 days after resection from 
multiple organ failure. 
The third patient died of hepatic failure 29 days after right triseg-
mentectomy and duct reconstruction of the left lateral segment to 
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the Roux-en-Y jejunum for bile duct cancer at the hepatic hilum. 
The fourth patient with hepatoma in a cirrhotic liver died of myocar-
dial infarction and liver failure 28 days after right lobectomy. The last 
patient died of hepatic failure and pneumonia 20 days after right 
lobectomy for a large hepatocellular carcinoma in a cirrhotic liver. 
This patient was a chronic hepatitis B surface antigen carrier, whose 
tumor had grown and ruptured behind the right colon. 
Another perspective is provided by correlating the data in Table 3 
and Table 4. The only patients with benign disease who died were 2 
with traumatic injury severe enough to require trisegmentectomy, 1 
with an iatrogenic liver abscess, and 1 other with cirrhosis, whose 
regenerative nodule was misdiagnosed. Trisegmentectomy was asso-
ciated with the highest mortality of any of the resections (5.5%), but 
5 of the 9 deaths after trisegmentectomy resulted from treating very 
extensive primary hepatic malignancies, and 2 more occurred after 
the treatment of massive hepatic trauma. Exclusive of these high-risk 
cases, the operative mortality of trisegmentectomy would have been 
less than 2%. 
Although further reduction must be achieved, our operative mor-
tality has been acceptable when compared with those of others in 
recent years.70- 72, 142, 143 
POSTOPERATNE COMPLICATIONS 
There were 57 major complications, some patients having more 
than one, and they are stratified by the extent of resections and 
listed in Table 5. The most frequent complication was subphrenic 
abscess, which occurred in 27 patients, all but 1 after right-sided re-
section. The incidence was by far the highest after right trisegment-
ectomy (14%). Fluid collection or blood clots in the subphrenic 
space were treated as subphrenic abscess when occurring in pa-
tients with fever and/or leukocytosis. These were drained surgically 
by the posterior route through the 12th rib or on some occasions by 
transcutaneous tube drainage without delay. With this aggressive 
approach only 3 of the 27 patients with subphrenic abscess died af-
ter the drainage procedure, all from hepatic failure. 
Minor bile leaks through the drain were seen occasionally, but 
these all closed spontaneously within a few days. Prolonged bile 
leaks occurred in 14 patients. All of these major bile leaks closed 
spontaneously without surgical correction within 2 months. In 2 pa-
tients prolonged bile leaks were followed by the later development 
of subphrenic abscess, which was surgically drained successfully. 
Prolonged bile leaks were most frequently seen after left trisegmen-
tectomy (32%). 
Seven (1.5% i of the 473 patients required re-exploration for postop-
erative bleeding. Hemorrhage was from the cut surface of the liver in 
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TABLE 5. 
Postoperative Major Complications in Relation to Extent of Hepatic Resection' 
IUS I;[S RL LL U.S Local Total 
In=144) In=191 In=130) In=53) In=29) In=98) In=473) 
Subplmmic 20 5 0 0 1 27 
abscess 
Prolonged 3 6 3 0 14 
bile leak 
Postoperative 3 0 1 0 2 7 
bleeding 
Gl tract 3 0 0 0 0 0 3 
bleeding 
Deep vein 1 0 1 0 0 0 2 
thl'Ombosis 
Myocal'dial 0 0 0 0 0 1 
infarction 
Cerebrovascular 0 0 2 0 0 0 2 
accident 
Small bowel 0 0 1 0 0 
obstruction 
Total 30 7 14 2 0 4 57 
'RTS = right trisegmelltectomy; LTS = left trisegmpl1lectomy; RL = right lobectomy; LL = left lobec-
tomy; LLS = left lateral segmentectomy; local = nonanatomical local excision; GI = gastrointestinal. 
6 patients and from the cystic artelY in 1 patient. All but 2 patients 
recovered without additional complication. One of the 2 patients 
who bled after right lobectomy for pseudohepatoma died of liver 
failure as described earlier, and another patient with hemangioma 
developed a subphrenic abscess that was drained successfully. 
Three patients had major bleeding from stress ulcer in the stomach 
and duodenum after trisegmentectomy. Two died of hepatic failure 
a few days after ulcer surgely. One patient smvived stress ulcer and 
liver failure and is alive and well 6 months after hepatic resection. 
Other complications such as deep vein thrombosis, myocardial in-
farction, cerebral vascular accident, and small bowel obstruction 
were managed successfully. 
HEPATIC RESECTION FOR BENIGN LESIONS 
With the recent advances in imaging techniques, space occupying 
lesions of the liver are now detected rather frequently. Although var-
ious imaging techniques are quite accurate in identifYing cysts and 
hemangiomas, other lesions such as adenomas, focal nodular hyper-
plasia, and other benign solid tumors cannot be diagnosed with a 
high degree of confidence. Benign hepatic tumors sometimes cause 
life-threatening complications and more often trigger disabling and 
quite annoying symptoms in otherwise healthy persons. 
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TABLE 6. 
Indications for 473 Hepatic Resections 
1yPe of Lesion 
Benign Hepatic Lesion 
Cavernous hemangioma 
Adenoma 
Focal nodular hyperplasia 
Congenital cyst 
Polycystic disease 
Nonpolycystic disease 
Trauma 
Hydatid cyst 
Abscess 
CaroJi's disease 
Fibroma 
Leiomyoma 
Mesenchymal hamartoma 
Mesenchymoma 
Regenerative nodule 
Organized hematoma 
Total 
PJimary Hepatic Malignancy 
Hepatocellular carcinoma (HeCI 
Fibrolamellar BCC 
N onfibrolamellar 
Cholangiocarcinoma (eHe) 
Bile duct cancer 
Carcinoma of hepatic cyst wall 
Leiomyosarcoma 
Adenocarcinoma of gallbladder 
Rhabdomyosarcollla 
Hepatoblastoma 
Neuroendocrine tumor 
Angiosarcoma 
Sarcoma. undetermined cell type 
Adenocarcinoma. unknown pJimarv 
Unclassified malignancy 
Total 
GIANT CAVERNOUS HEMANGIOMA 
No. of 
Patients 
109 
23 
19 
17 
6 
11 
11 
5 
5 
2 
1 
1 
1 
1 
1 
197 
76 
12 
64 
15 
9 
4 
4 
3 
2 
2 
2 
1 
3 
123 
(Continued.) 
There were 109 patients in our series whose giant cavernous he-
mangiomas were surgically excised (Table 6). T\venty-six were men 
and 83 were women. The patients' ages ranged from 22 to 77 years, 
with a mean age of 46 years. Twenty-two of the 109 patients had 
multiple hemangiomas. The masses ranged from 4 em to 41 em in 
largest diamater with a mean of 12 em. Focal nodular hyperplasia 
coexisted in 3 female patients and hamm10ma in 2 male patients. 
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TABLE 6 (cont.). 
Indica tions for 473 Hepatic Resec tions 
Type or Lesion 
Secondaly Hepatic Malignancy 
Colorectal cancer 
Intestinal cancer 
Carcinoid 
Spindle cell sarcoma 
Leiomyosarcoma 
Kidney cancer 
Renal ce ll cancel' 
Wilms ' tumor 
Adrenal cancel' 
Adrenocortical carcinoma 
Neuroblastoma 
Breast cancer 
Adenocarcinoma 
Comedocal'Cinoma 
Angiosal'Coma 
Gastric leiomyosarcoma 
Ovarian adenoca rcinoma 
Uterus cancel' 
Squamous cell ca ncer 
Endometlial sa l'COIlla 
Me lanoma 
GlucagonoIlla , pancreas 
Leiomyosarcoma, rectum 
Thyroid meduUary carcinoma 
Ewing's sal'Coma 
Mesothelioma 
Rhabdomyosarcoma, colon 
Adenocarcinoma, stomach 
Total 
No. or Patients 
153 
118 
6 
4 
5 
3 
2 
5 
4 
4 
2 
2 
2 
2 
2 
1 
1 
153 
Surgical removal of the hemangioma was decided in 30 patients 
because of severe pain associated with rupture or hemorrhage into 
the necrotic center of the tumor. The hemangioma ruptured sponta-
neously in 2 patients, resulting in hemoperitoneum or hemobilia. In 
8 patients hemorrhage followed unwise percutaneous needle biopsy 
or open biopsy. In the remaining 20 patients hemorrhage occurred 
spontaneously into the necrotic center of the giant hemangioma and 
in these patients preoperative dynamiC CT scan predicted the path-
ologic findings accurately (Fig 54), The patients with this complica-
tion noticed an enlarging palpable abdominal mass or hepatome-
galy, accompanied by severe abdominal pain . 
The indication of excision was moderate to severe pain in 49 pa-
tients. The pain was almost always located in the right upper quad-
rant or the epigastrium, and frequently radiated to the back and the 
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FIG 54. 
Giant cavernous hemangioma with cen tral necrosis 
shoulder. The diagnostic workup of gallbladder disease or peptic ul-
cer disease often led to the discovery of hepatic lesions. The gall-
bladder disease actuaUy coexisted in 4 patients. 
Vague but annoying symptoms of long duration, caused by a large 
abdominal mass, were the main indication for surgery in 17 patients. 
These symptoms consisted of all or any combinations of shortness 
of breath , abdominal fullness, pressure and dull ache, early satiety, 
nausea, vomiting, fatigue , night sweats, fever, and weight loss. In 13 
patients the hemangiomas were relatively or completely asymptom-
atic, but in 10 of these patients the specific diagnosis could not be 
malic with certainty in spite of an extensive workup. Eight of the 10 
patients had a history of previous malignancy. In the remaining 2 
patients CT scan revealed a large central necrosis in the relatively 
asymptomatic giant cavernous hemangioma. 
Hematologic abnormalities were noted in 15 patients: 11 patients 
had anemia with a hemoglobin value of less than 10 gm/dL 3 pa-
tients had a platelet count of less than 100,000/cu mm, and 1 patient 
carried a diagnosis of pI'imary fibrinolysis for several years. These ab-
normalities were all corrected after the removal of the hemangioma. 
Infertility and miscarriage were noted in 4 young women. 
Fourteen trisegmentectomies, 34 lobectomies, 8 left lateral seg-
mentectomies, and 53 nonanatomical resections were used to re-
move the giant hemangiomas (see Table 3). The trisegmentectomies 
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and lobectomies were reserved for very large lesions (see Fig 54) or 
for hemangiomas located deep inside the liver, but some of the mas-
sive hemangiomas could be removed by local excision if they were 
pendulous or had narrow pedicles. Some of the medium-sized he-
mangiomas located on the edge of the liver could also be enucleated 
using the pseudocapsule of the hemangioma as a dissection plane. 
All 109 patients sUl\rived the operation and were followed up for at 
least several months, after which further visits were not encouraged. 
However, 79 patients were traced for this report after 1 to 15 years 
(mean, 5 years). Four patients had died of malignancies that had 
been diagnosed before hepatic resection (chronic lymphocytic leu-
kemia, testicular carcinoma, lung carcinoma and hypernephroma). A 
fifth patient died of colon carcinoma diagnosed 6 years after hepatic 
resection. Of the surviving patients none developed late complica-
tions except 1 who had an incisional hernia. Two of the patients de-
veloped acute hepatitis with recovery long after operation. 
Sixty-one of 79 patients had had significant symptoms before he-
patic resection. One or more years after resection 55 of the 61 were 
symptom free, but 6 still had vague abdominal complaints which 
were different from prevous ones. Among the 18 patients who had 
been relatively asymptomatic preoperatively, 14 had no major symp-
toms and the other 4 had died from pre\riously known malignancies 
before the follow-up contact. Although in 3 patients small hemangi-
omas (less than 2 cm in diameter) were known to be left unexcised, 
no recurrence of a symptomatic hemangioma is known to us at this 
time. 
In general, it is safe to observe asymptomatic hemangiomas of 
moderate size closely. Danger of hemorrhage is low and there is 
no reason for therapy in the majority of patients with these le-
sions.136.139, 141,144 However, the magnitude of symptoms should not 
be the only determinant for excisional therapy, Relatively asymptom-
atic hemangiomas 10 cm or more in diameter with documented 
central necrosis must be managed differently, Two of the 25 patients 
with such lesions in our series hild emergency surgery for rupture, 
and 16 other patients required urgent operations for the sudden on-
set of severe pain and an acutely enlarging mass. 
At surgery each patient was found to have hemorrhage inside the 
necrotic center of a giant hemangioma. Therefore we believe that 
this type of hemangioma should be excised, while they are still rela-
tively asymptomatic, Hepatic artery ligation or embolization, and ir-
radiation of the symptomatic giant cavernous hemangiomas had 
been recommended in the past because the mortality from any of 
the major hepatic resections was too high and extensive resection 
was thought unjustified for benign hepatic lesions. These modalities 
of treatment are no longer employed because they are ineffective; 
moreover, hepatic resection can now be carried out quite safely. 
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It is worth noting here that we h ave experienced at least 5 pa-
tients who had been thought to have typical imaging characteristics 
of hemangioma preoperatively but actually had malignant tumors: 3 
patients had hepatocellular carcinoma, 1 patient had metastatic ad-
renal carcinoma, and another had multiple epithelioid hemangioen-
dothelioma. 
LNER CELL ADENOlvlA (ADENOlvlA) 
There were 23 patients whose adenomas were surgically removed 
(see Table 61. Five were male and 18 were female. Ages ranged from 
16 to 60 years, with a mean of 31 years. Ten of the women had a 
history of using birth control pills or estrogen therapy. Five of the 23 
patients, 2 men and 3 women, had multiple adenomas. Tumor size 
ranged from 5 to 27 cm in the greatest diameter, with a mean of 12 
cm . One male patient had a parathyroid adenoma and 1 female pa-
tient had focal nodular hyperplasia. Si.;xteen of the 23 patients had 
moderate to severe abdominal pain and 4 more had vague abdomi-
nal complaints, similar to those described previously in patients 
with hemangioma. Six patients presented to us with hemoperito-
neum from a ruptured adenoma (Fig 55). Four other patients with 
spontaneous hemorrhage into the necrotic center of the adenoma 
developed excruciating pain . Only 3 patients were asymptomatic, 
their solid tumors being found inCidentally during physical exami-
nation for an unrelated illness or during abdominal exploration for 
another lesion. These asymptomatic adenomas were excised be-
cause of their large size, or because a definitive diagnosis could not 
be established preoperatively. 
Lobectomies or trisegmentectomies were necessary in 21 of the 23 
patients (see Table 3). Each of the 23 patients survived and all pa-
tients were available for postoperative evaluation between 3 months 
and 18 years (mean , 6 years) after surgery. In 3 patients with mul-
tiple adenomas that involved all four segments of the liver, some 
of the lesions were left behind after right trisegmentectomy. In 
each case the remaining adenomas enlarged or new lesions de-
veloped. One of these patients died of liver failure 6 years after re-
section. Another patient died 5 years after resection from CIYP-
tococcosis, a complication of her acquired immunodeficiency syn-
drome. The remaining patient required liver transplantation for 
massive adenoma regrowth 1 year after right trisegmentectomy 
and is alive and well 6 years after liver transplantation.141 No other 
recurrence of adenoma is known to u s at this time . Nine teen pa-
tients are free of symptoms after resection, and 2 others still have 
vague abdominal complaints that are different from previous symp-
toms. 
The well-known propensity of hepatic adenomas to r'upture, with 
360 Curr Probl Surg, May 1989 
FIG 55. 
Spontaneous rupture of multiple liver cell adenoma. Note massive hemoperitoneum . 
life-threatening hemorrhage) was seen in almost half of our patients . 
It is sometimes difficult histologically to differentiate liver cell ade-
noma from well-differentiated hepatocel1ular carcinoma even after 
the removal of the tumor, as illustrated in two of our patients. In one 
patient a large tumor was removed by right lobectomy with wide tu-
mor-free margins . The tumor was his tologically diagnosed as an ad-
enoma. Two years later, the patient developed a pathologic frac ture 
of the right femur. After examination of the bone lesion, the previous 
diagnosis of adenoma was corrected to well-differentiated hepato-
cellular carcinoma. 
In another patient a large tumor was removed by nonanatomic he-
patic resection. The diagnosis of adenoma established preopera-
tively by needle biopsy at another institution was confirmed after re-
moval of the tumor. Several years later the tumor recurred in the 
same area, and it was resected by right lobectomy with wide mar-
gins . After the lobectomy the diagnosis was corrected to weB-differ-
entiated hepatocellular carcinoma . For these reasons, the argument 
for conservatism in treating adenomas is hard to sustain 145 It is best 
to treat the adenoma as a potential malignancy and resect it with 
\-vide margins . Twenty-one of our 23 patients with adenoma were 
treated with anatomical resection, and only 2 patients with a small 
adenoma along the edge of the liver were treated by nonanatomical 
resections with wide margins. 
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FOCAL NODUlAR HYPERPIASU\ 
Nineteen patients, aJI female , had excisional therapy for focal nod-
ular hyperplasia (see Table 6). Their ages ranged from 20 years to 52 
years, with a mean of 35 years. Fourteen patients had used birth 
control pills. The size of the tumors ranged from 4 to 14 cm, vvith a 
mean of 8 cm in the largest diameter. Two patients had multiple le-
sions. 
Symptoms were usually milder in these patients than in those 
with cavernous hemangiomas or adenomas, and in 4 patients the le-
sions were found incidentally. One patient had had ovarian carci-
noma and another had a malignant histiocytoma of the skin . The de-
finitive diagnosis was not made preoperatively in any case, aJthough 
the diagnosis was often suspected. 
Three trisegmentectomies, 4 lobectomies, 1 lateral segmentec-
tomy, and 11 nonanatomicaJ local excisions were performed with no 
operative death (see Table 3), Fifteen of the 19 patients were evalu-
ated in 1988 after a follow-up of 6 months to 11 years, mean 3 years . 
All of the 12 patients who had had Significant symptoms were now 
symptom-free, but 3 patients had some vague abdominal com-
plaints . No recurrence of this lesion is known to us during the fol-
low-up . 
Patients with focal nodular hyperplasia, which at one time was 
confused with adenoma/46 can be observed closely if the diagnosis 
is absolutely certain since these lesions rarely cause life-threatening 
complications such as rupture or internal hemorrhage.46• 147 The di-
agnosis of focal nodular hyperplasia by imaging techniques is not as 
dependable as is the diagnosis of hemangioma or hepatic cyst. His-
tologic diagnosis is relatively easy for FNH, but we have experienced 
several cases in which the differential diagnosis with adenoma was 
confusing, and on one occasion the diagnosis by a frozen section bi-
opsy was later changed to fibrolamellar hepatocellular carcinoma af-
ter removal of the tumor. As mentioned in the section on adenoma, 
some of our patients had both a hepatic adenoma and focal nodular 
hyperplasia occurring simultaneously. 
CONGENITAL CYSTS 
Seventeen patients in our series with congenitaJ cysts were treated 
by excisional therapy. Two patients had widespread polycystic dis-
ease and 4 others had multiple cysts that were limited to the re-
sected specimen . The remaining 11 patients had single congenital 
cysts (see Table 6). All of these patients with large cysts had signifi-
cant symptoms and had had repeated aspiration of cyst fluid. Two 
of the 6 patients with polycystic disease (Fig 56) had required intra-
venous alimentation for nutrition and the continuous administra-
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FIG 56. 
Polycyslic disease of the liver. 
tion of narcotics for severe pain. Ten of the 17 patients had fever and 
chills, and 4 of them had jaundice. Seven trisegmentectomies, five 
lobectomies, and five nonanatomicallocal excisions were performed 
with no mortality. 
The 2 patients with severe polycystic disease (see Fig 56) had right 
trisegmentectomy or right lobectomy, leaving a lateral segment or 
the left lobe that had fewer and smaller cysts than the rest of the 
liver. There was marked symptomatic relief for several years, but 
eventually there was cystic enlargement of the cysts in the remain-
ing portion of the liver almost to the original size. One of these pa-
tients required orthotopic liver transplantation 8 years after right 
lobectomy. In contrast to the recurrence after partial resection of 
widespread polycystic disease, none of the patients whose cyst or 
cysts could be completely resected has had subsequent difficulties 
during a follow-up of 1 to 15 years. 
Aspiration,148 internal drainage/49 marsupialization/50 fenestra-
tion/51 and sclerotherapy152 have all been recommended for con-
genital hepatic cysts. These therapies can no longer be justifiable 
treatment for single or localized multiple cysts because resection 
can be performed so safely. 
The problem of missed diagnOSis was also experienced in 4 of our 
patients with single hepatic cysts. Three of the 4 patients had been 
diagnosed as having benign congenital cysts, and the cysts had been 
drained through jejunal Roux limbs at other institutions prior to our 
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seeing them. Pain) fever and intermittent jaundice developed or re-
developed after internal drainage of the cysts. By the time we per-
formed resection, squamous cell carcinoma of the cyst wall had 
spread regionally in these 3 patients. They died of widespread can-
cer within 6 to 16 months . The only survivor had primary nonana-
tomical resection of the cyst after repeated aspirations. The exami-
nation of the cyst wall after resection revealed a small adenocar-
cinoma. The patient is well and tumor-free 16 months postopera-
tively. 
We have successfully treated 2 other patients with severe polycys-
tic disease involving both the liver and the kidneys by combined 
liver and kidney transplantation. The quality of life of the 2 trans-
plant patients is much better than that of patients after partial he-
patic resection . If confronted with extreme complications of polycys-
tic disease today, we would recommend organ replacement as the 
first, not the last, step of therapyl41 
HYDATID CYST 
Five patients with hydatid cyst were treated by trisegmentectomy 
(I) , lobectomy (3) , and local excision (1 ) (see Tables 3 and 6). One pa-
tient with a small hydatid cyst died from pancreas cancer 10 months 
after local excision of the cyst. The remaining 4 patients are alive, 
free of hydatid disease from 1 to 12 years after anatomical resection 
of the liver. 
The most widely used treatment of hydatid cyst has been the re-
moval of the lining membrane and all cyst contents after sterilizing 
the paracytes with formalin, alcohol or hypertonic saline solution .1s3 
Besides the toxicity of the sterilizing solution and the occasional 
damage to the biliary duct, the cyst frequently recurs when the para-
cytes escape alive. Although small, satellite cysts adjacent to a dom-
inant one are frequently not recognized, and these tend to grow 
progressively after the larger cysts are treated . Although our ex-
perience is limited to only 5 cases, 2 of these patients had had 
multiple operations over a period of years at outstanding clinics in 
the United States and Europe. Increasingly complex problems 
had developed, such as communication between the cyst and the 
biliary duct and growth of satellite cysts. Despite this, all of the le-
sions could be removed by a difficult trisegmentectomy and lobec-
tomy. 
We believe that a large cyst or multiple cysts should be excised by 
anatomical resection whenever feasible, and that the cystectomy be 
only reserved for cases in which the cysts cannot be removed by 
partial hepatic resection. We have treated a young woman by liver 
transplantation who had developed sclerosing cholangitis and cir-
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rhosis after sterilization by formalin and cystectomy. Another young 
patient died during an attempt at liver transplantation after several 
operations in Europe had cured the hydatid cysts, but she had re-
sultant sclerosing cholangitis. 
OTHER BENIGN HEPATIC LESIONS 
Eleven patients were treated with trisegmentectomy (4), lobectomy 
(6), and lateral segmentectomy (1) of the traumatized liver (see Ta-
bles 3 and 6). Six resections were for acute hemorrhage, 4 were for 
post-traumatic abscess and 1 for bile peritonitis after repair of lacer-
ation. Two of the 11 patients died postoperatively of various causes 
as described in the earlier section. 
Five patients with hepatic abscess were treated with four ana-
tomic resections and one nonanatomical resection. Two patients 
with iatrogenic abscess following cholecystectomy had been unsuc-
cessfully managed by percutaneous drainage. One patient with fun-
gal abscess of unknown origin was thought to have necrotic malig-
nant tumor preoperatively. Two of the 5 patients died postopera-
tively of infectious complications and hepatic failure, as shown in 
Table 4. 
Eight other patients with various benign hepatic lesions had he-
patic resection. Miscellaneous diagnosis and the procedures used 
are summarized in Table 3 and 6. Two patients had right lobectomy 
for localized Caroli's disease. The death of a patient with pseudohe-
patoma was described in the earlier section. In none of the other 5 
patients could a correct diagnosis be made preoperatively. 
HEPATIC RESECTION FOR PIDMARY HEPATIC MALIGNANCY 
Histologic diagnoses of the 123 patients with primary hepatic ma-
lignancy are shown in Table 6. There were 76 patients with hepato-
cellular carcinoma (HCC), of whom 12 had fibrolamellar hepatocellu-
lar carcinoma (FL-HCC). Fifteen patients had peripheral cholangio-
carcinoma (CHC) and 9 had bile duct cancer at the bifurcation 
(Klatskin tumor). The remaining 23 patients had various rare types of 
primary malignancy, in some of whom a definitive histologic diagno-
sis could not be made. 
More than a half of the patients (66 of 123) were treated with tri-
segmentectomies, and most of the patients 1108 of 123) with lobecto-
mies or greater resections, reflecting the extremely high incidence of 
advanced stages of malignant tumors among our patients (see Table 
3i. Eight of the 12 operative deaths would have been avoided if or-
thotopic liver transplantation had been chosen for these patients 
(see Table 5). 
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SURVNALS 
The actuarial survivals of patients with primary hepatic malig-
nancy are shown graphically in Figures 57 and 58. Overall survival 
rates of 123 patients with primary hepatic malignancy, including op-
erative deaths, were 85% at 3 months, 80% at 6 months, 69% at 1 
year, 55% at 2 years, 46% at 3 years, 38% at 4 years, and 33% at 5 
years after hepatic resection. Similar results have been reported by 
others.72, 142, 143 
All but 1 of the 12 patients with fibrolamellar hepatocellular carci-
noma are alive (see Fig 58): 9 patients are free of disease from 2 to 16 
years after resection, and 2 are with disease from 2 to 4 years after 
resection. One patient died 8 years after hepatic resection during an 
attempt at en bloc liver and pancreas transplantation for recurrent 
tumor that obstructed the portal vein. One- to 5-year survival rates of 
64 patients with nonfibrolamellar hepatocellular carcinoma were 
77%, 69%, 50%, 37% and 26%, respectively, and those of 15 patients 
with cholangiocarcinoma were 50% I 40% I 40% I 40% I and 40% I re-
spectively (see Fig 58). The survival of patients with fibrolamellar he-
patocellular carcinoma was significantly better than the survival of 
patients with nonfibrolamellar hepatocellular carcinoma and pa-
tients with cholangiocarcinoma (P < .01). There was no difference in 
survival between patients with nonfibrolamellar hepatocellular carci-
noma and patients with cholangiocarcinoma (P < .05). 
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FIG 57. 
After hepatic resection there was no difference in actuarial survival rates between 123 pa-
tients with primary hepatic malignancy and 153 patients with secondary hepatic malig-
nancy. 
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FIG 58. 
After hepatic resection the survival rate of patients with fibrolamellar hepatocellular carci-
noma was higher (P < .01) than that of patients with nonfibrolamellar hepatocellular carci-
noma and higher than with cholangiocarclnoma. 
Nine patients with carcinoma of the bile duct bifurcation IKlatskin 
tumor) were treated with right trisegmentectomy (6), or left triseg-
mentectomy 11), left lobectomy (II, and left lateral segmentectomy 
(1). In these patients the tumor bearing extrahepatic bile ducts were 
excised and the remaining bile duct was anastomosed to the Roux-
en-Y jejunum. Three ofthe 9 patients died: 1 from liver failure within 
a month and 2 others from recurrent tumor, 8 months and 4 years 
after operation. The remaining 6 patients are alive between 6 months 
and 18 months after resection, but 2 have recurrent tumor. 
The 4 patients with single hepatic cysts that had malignant degen-
eration in the cyst wall were treated by trisegmentectomy (3) and lo-
cal nonanatomical resection (1). The 3 patients treated with triseg-
mentectomy died from recurrence of squamous cell cancer 6, 10, 
and 16 months after resection. The fourth patient whose solitary 
cyst contained a small adenocarcinoma is alive and free of tumor 18 
months after local excision. 
FNE-YEAR SURVNORS 
There were 18 patients who sUIvived more than 5 years after he-
patic resection for primary hepatic malignancy (Table 7). Five of 
them had had fibrolamellar hepatocellular carcinoma, all of which 
were resected by trisegmentectomy. One patient died 8 years after 
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TABLE 7. 
Follow-up of 18 Patients With Primary Hepatic Malignancies Who 
Lived for 5 Years* 
Histology Fibrolamellar HCC ClIC Other 
Number 5 6 4 3 
'I'ri segmentectomy 5 4 2 3 
Lobectomy 0 2 1 0 
Died> 5 yr 1 2 1 1 
Time of death iyrl 8 8,8 6 13 
Living> 5 yr 4 4 3 3 
5wvival lyrl 6,8,9,15 5,7,7,13 6t,7t,8 13,14 
Total 
18 
14 
3 
4 
14 
'Fibrolamellar = fibrolamellar variant of hepatocellular carcinoma; HCC = nonfibrolamellar 
hepatocellular carcinorna: CHC ~ cholangiocarcinonla: other = hepatoblastoma, leiomyo-
sarconla, i'habdolnyosal'coma. 
tLiving with recurrence 
hepatic resection during an attempt at en bloc liver-pancreas trans-
plantation as described earlier, The remaining 4 patients are alive 
and free of tumor from 6 to 15 years after resection. Six patients with 
nonfibrolamellar hepatocellular carcinoma also survived more than 
5 years. Four of the 6 patients were treated by trisegmentectomy and 
2 by lobectomy, Two of the 6 patients died 8 years after resection 
from recurrent tumor, The remaining 4 patients are alive and ti'ee of 
tumor between 5 and 13 years after resection, 
Four patients with peripheral cholangiocarcinoma survived more 
than 5 years, However, 1 patient died from recurrent tumor 6 years 
after resection, and 2 patients are alive with recurrent tumor in the 
sixth and seventh year after resection. Only 1 patient is alive and free 
of tumor 8 years after resection, Three other patients survived more 
than 3 years after trisegmentectomy for hepatoblastoma, leiomyo-
sarcoma, and rhabdomyosarcoma, One patient with hepatoblastoma 
died of acute leukemia 13 years after hepatic resection, The remain-
ing 2 patients are alive and free of tumor 13 and 14 years after resec-
tion, It is worth noting that 14 of the 18 5-year survivors had been 
treated by trisegmentectomy for removal of their large tumors, 
HEPATIC RESECTION FOR SECONDARY HEPATIC 
MALIGNANCY 
PrimalY sites of malignancy and histologic diagnoses of 153 pa-
tients with hepatic metastases are shown in Table 6, There were 118 
patients vvith hepatic metastases from colorectal carcinoma, and 35 
patients with metastases from various other primary sites, The fact 
that more than one third of the patients were treated with triseg-
mentectomy and the vast majorty (128 of 153) of patients required 
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lobectomy or larger resections indicates the high incidence of ad-
vanced metastatic disease among our patients (see Table 3). 
There was no operative death among 153 patients with hepatic 
metastases as described earlier. 
SURVNALS 
The overall actuarial survival rates of 153 patients with hepatic me-
tastases are shown graphically in Figure 57: 99% at 3 months, 96% at 
6 months, 84% at 1 year, 65% at 2 years, 51 ()7o at 3 years, 40% at 4 
years and 31 % at 5 years after resection. 
The 1- to 5-year survivals of 118 patients with metastases from col-
or-ectal carcinoma were 90%, 69%, 52%, 40% and 37%, respectively 
IFig 59). The similar survivals of the 35 patients with metastases from 
primaries other than colorectal carcinoma were 75%, 54%, 47%, 38% 
and 20%, respectively (see Fig 59). The difference in survival was 
not statistically significant. Similar results have been noted by oth-
ers?O.81.154 
FNE-YEAR SURVNORS 
There we['e 16 patients who sUivived more than 5 years after he-
patic resection for metastases ITable 8). Eleven of them had had me-
tastases from colorectal carcinoma, 2 had had carcinoid tumor of 
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FIG 59. 
After hepatiC resection there was no difference in actuarial survival rates between 118 pa-
tients with colorectal metastasis and 35 patients with other metastases. 
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TABLE 8. 
Follow-up of 16 Patients With Hepatic Metastases Who Survived for More 
Than 5 Years After Hepatic Resection 
Histology Colorectal Carcinoid Others' Total 
Number 11 2 3 16 
Trisegmentectomy 2 0 3 5 
Lobectomy 5 1 0 6 
Lateral Segmentectomy 4 1 0 5 
Died> 5 yr 3 1 0 4 
Time of death (yr) 6t,7t,S* st 
Living> 5 yr 6 1 3 9 
Survival lyrJ 5t,5t,6t 9 5,15,15 
7,S,14 
Lost to follow-up lyrJ 6*,S 2 
*One each of leiolllyosarcolna of :stOlnach, adrenal ncuroendocIine tumor! and en-
dometrial sarcoma of uterus. 
tHad recurrence when last seen. 
*Died of myocardial infarction, tumor free. 
the intestine, and 3 others had had leiomyosarcoma of the stomach, 
an adrenal neuroendocrine tumor and endometrial sarcoma of the 
uterus, Five of the 16 patients were treated with trisegmentectomy, 6 
with lobectomy and the other 5 with less than lobectomy. 
Three of the 11 5-year survivors with metastases from colorectal 
carcinoma died: 2 from tumor recurrence and 1 from myocardial in-
farction without evidence of tumor recurrence. Six of the 11 patients 
are alive from 5 to 14 years after hepatic resection: 3 with and 3 with-
out tumor recurrence. The remaining 2 of the 11 patients were lost 
from follow-up after 5 years: 1 in the sixth year with known tumor 
recurrence and another in the 8th year with no evidence of recur-
rent tumor. 
One of the 2 patients with metastatic carcinoid tumor died with 
recurrent tumor 8 years after resection and another patient is alive 
and free of tumor 9 years after resection. Three other patients are 
alive and free of tumor: 5 years after hepatic resection for endome-
trial sarcoma, 15 years after hepatic resection for leiomyosarcoma of 
the stomach and 15 years after hepatic resection for adrenal neu-
roendocrine tumor. 
THE CHANGING FACE OF HEPATIC RESECTION 
Hepatic resection has evolved from the speedy amputation of he-
patic lesions decades ago to well-controlled removal of anatomically 
defined portions of the liver in the middle of this century, when pre-
cise anatomy of the liver was finally understood. In the 1960s and 
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1970s malignant tumors were treated aggressively by major anatom-
ical hepatic resections, but the operative mortality was so high that 
this most effective surgery was not employed for patients with be-
nign lesions.ISS,IS6 During this period less effective but safer proce-
dures for benign hepatic lesions were introduced, and the conserva-
tism in treating these lesions spread widely. In the 1980s the safety 
of major anatomical hepatic resection has been well established, 
and the indications for hepatic resection must be broadened. Rigid 
conservatism in treating benign hepatic lesions can no longer be jus-
tified.141 
Also in the 1980s hepatic transplantation38,39 has become a prac-
tical therapeutic modality not only for acute and chronic hepatic 
failure, but also for benign and malignant hepatic lesions. Massive 
benign hepatic lesions such as multiple adenomas, polycystic dis-
ease and lymphoangiomatosis have been treated successfully by to-
tal hepatectomy and transplantation.3B,39 The results after hepatic 
transplantation for malignant tumors have been rather discour-
aging.39, 157-159 Although the survival for the first year has been very 
high, late tumor recurrence has plagued these efforts. In the past, 
adjuvant chemotherapy, radiotherapy, and biologic therapy for ma-
lignancy have not been systematically tried after transplantation. 
Liver transplantation, however, can result in the cure of hepatic 
malignancy on more than the isolated occasion. The most favorable 
lesions for hepatectomy and transplantation, just as for resection, 
are small lesions, fibrolamellar hepatomas and epithelioid heman-
gioendothelial sarcomas. IS7 Even in highly selected cases of meta-
static hepatic tumors significant palliation or even long survival has 
been accomplished.39, 160 
The most recent development is the en bloc removal and replace-
ment of upper abdominal organs (organ-cluster transplantation) for 
regionally spread hepatic, biliary, pancreatic, and duodenal malig-
nancy. The liver, pancreas, duodenum, and even a part of the small 
intestine have been grafted in continuity in 7 patients. Five of the 7 
patients are yet alive, free of tumor, within several months. 
Lest these remarks be misunderstood, it should be pointed out 
that in addition to demonstrating how safe hepatic resection and 
transplantation can be, our observations have also shown that the 
real key to the cure of malignant tumors is nonsurgical. While the 
yield from complete surgical removal of hepatic malignancy was 
substantial in our patients, tumor recurrence was the rule, not the 
exception.lS7-160 The recurrence must be prevented by nonsurgical 
therapy. With the development of safer and more effective chemo-
therapy, radiotherapy, and immunotherapy, hepatic resection and 
transplantation will become reliable adjuvant therapies for malig-
nant disease in the future. 
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